# Stryker Corporation timeline

entity: /record/stryker.md  
id: ent_stryker  

Stryker Corporation's timeline holds 589 money & deals claims from 2006 to 2026. The latest took effect on September 30, 2026.

Kinds: People 1 (/timelines/stryker.md?kind=people) · Money & deals 589 (/timelines/stryker.md?kind=money) · Products 0 (/timelines/stryker.md?kind=products) · Models 0 (/timelines/stryker.md?kind=models) · Other 9 (/timelines/stryker.md?kind=other) · every kind: /timelines/stryker.md  
Format: date | kind | predicate | value | status | claim.

## 2006

- 2006-12-31 to 2007-12-31 | money | cash_and_equivalents | 416,600,000 United States dollar | superseded | [clm_F770CAB41FDC](/claim/clm_F770CAB41FDC.md)
- 2006-12-31 to 2007-12-31 | money | total_equity | 4,191,000,000 United States dollar | superseded | [clm_AF9FF365F979](/claim/clm_AF9FF365F979.md)

## 2007

- 2007-12-31 to 2008-12-31 | money | cash_and_equivalents | 290,500,000 United States dollar | superseded | [clm_DAEA8CC5073D](/claim/clm_DAEA8CC5073D.md)
- 2007-12-31 to 2008-12-31 | money | net_income | 1,017,400,000 United States dollar | superseded | [clm_BF11F68A601C](/claim/clm_BF11F68A601C.md)
- 2007-12-31 to 2008-12-31 | money | operating_income | 1,307,300,000 United States dollar | superseded | [clm_75486CA17271](/claim/clm_75486CA17271.md)
- 2007-12-31 to 2008-12-31 | money | research_and_development | 375,300,000 United States dollar | superseded | [clm_295A66A8882F](/claim/clm_295A66A8882F.md)
- 2007-12-31 to 2008-12-31 | money | revenue | 6,000,500,000 United States dollar | superseded | [clm_B62204F28676](/claim/clm_B62204F28676.md)
- 2007-12-31 to 2008-12-31 | money | total_equity | 5,378,500,000 United States dollar | superseded | [clm_69406B57602F](/claim/clm_69406B57602F.md)

## 2008

- 2008-06-30 to 2008-09-30 | money | quarterly_net_income | 305,800,000 United States dollar | superseded | [clm_28FD7932884B](/claim/clm_28FD7932884B.md)
- 2008-06-30 to 2008-09-30 | money | quarterly_operating_income | 400,900,000 United States dollar | superseded | [clm_B80F2C2FA315](/claim/clm_B80F2C2FA315.md)
- 2008-06-30 to 2008-09-30 | money | quarterly_research_and_development | 90,300,000 United States dollar | superseded | [clm_C4D2A72089DC](/claim/clm_C4D2A72089DC.md)
- 2008-06-30 to 2008-09-30 | money | quarterly_revenue | 1,712,600,000 United States dollar | superseded | [clm_1A3BD4C5AC92](/claim/clm_1A3BD4C5AC92.md)
- 2008-09-30 to 2009-03-31 | money | quarterly_net_income | 273,800,000 United States dollar | superseded | [clm_147721F941E8](/claim/clm_147721F941E8.md)
- 2008-09-30 to 2009-03-31 | money | quarterly_operating_income | 364,100,000 United States dollar | superseded | [clm_A74EC52E97FE](/claim/clm_A74EC52E97FE.md)
- 2008-09-30 to 2009-03-31 | money | quarterly_research_and_development | 92,600,000 United States dollar | superseded | [clm_10BC8BB0CDC0](/claim/clm_10BC8BB0CDC0.md)
- 2008-09-30 to 2009-03-31 | money | quarterly_revenue | 1,653,000,000 United States dollar | superseded | [clm_D56567958C98](/claim/clm_D56567958C98.md)
- 2008-12-31 to 2009-06-30 | money | cash_and_equivalents | 701,100,000 United States dollar | superseded | [clm_299A838D5950](/claim/clm_299A838D5950.md)
- 2008-12-31 to 2009-12-31 | money | net_income | 1,147,800,000 United States dollar | superseded | [clm_C3CE15157F07](/claim/clm_C3CE15157F07.md)
- 2008-12-31 to 2009-12-31 | money | operating_income | 1,519,000,000 United States dollar | superseded | [clm_224CD9F897E9](/claim/clm_224CD9F897E9.md)
- 2008-12-31 to 2009-12-31 | money | research_and_development | 367,800,000 United States dollar | superseded | [clm_AA8CC59B01C5](/claim/clm_AA8CC59B01C5.md)
- 2008-12-31 to 2009-12-31 | money | revenue | 6,718,200,000 United States dollar | superseded | [clm_629A9E88905C](/claim/clm_629A9E88905C.md)
- 2008-12-31 to 2009-06-30 | money | total_assets | 7,603,300,000 United States dollar | superseded | [clm_6E2B9A6171F9](/claim/clm_6E2B9A6171F9.md)
- 2008-12-31 to 2009-06-30 | money | total_equity | 5,406,700,000 United States dollar | superseded | [clm_DA10B9583E76](/claim/clm_DA10B9583E76.md)

## 2009

- 2009-03-31 to 2009-06-30 | money | quarterly_net_income | 281,100,000 United States dollar | superseded | [clm_FDC9598AC3EC](/claim/clm_FDC9598AC3EC.md)
- 2009-03-31 to 2009-06-30 | money | quarterly_operating_income | 379,200,000 United States dollar | superseded | [clm_9AD62A6BB17B](/claim/clm_9AD62A6BB17B.md)
- 2009-03-31 to 2009-06-30 | money | quarterly_research_and_development | 80,400,000 United States dollar | superseded | [clm_5D085B88D37F](/claim/clm_5D085B88D37F.md)
- 2009-03-31 to 2009-06-30 | money | quarterly_revenue | 1,601,300,000 United States dollar | superseded | [clm_F9DB51B074FD](/claim/clm_F9DB51B074FD.md)
- 2009-06-30 to 2009-09-30 | money | cash_and_equivalents | 666,300,000 United States dollar | superseded | [clm_517D8386F06F](/claim/clm_517D8386F06F.md)
- 2009-06-30 to 2009-09-30 | money | quarterly_net_income | 291,300,000 United States dollar | superseded | [clm_D55A2499EA2F](/claim/clm_D55A2499EA2F.md)
- 2009-06-30 to 2009-09-30 | money | quarterly_operating_income | 389,800,000 United States dollar | superseded | [clm_67A2A5CDB5F0](/claim/clm_67A2A5CDB5F0.md)
- 2009-06-30 to 2009-09-30 | money | quarterly_research_and_development | 82,600,000 United States dollar | superseded | [clm_DC9C02DB3BFB](/claim/clm_DC9C02DB3BFB.md)
- 2009-06-30 to 2009-09-30 | money | quarterly_revenue | 1,634,300,000 United States dollar | superseded | [clm_B0AE32FA5091](/claim/clm_B0AE32FA5091.md)
- 2009-06-30 to 2009-09-30 | money | total_assets | 7,923,500,000 United States dollar | superseded | [clm_9956441B013A](/claim/clm_9956441B013A.md)
- 2009-06-30 to 2009-09-30 | money | total_equity | 6,057,500,000 United States dollar | superseded | [clm_CC58F9B2FE3A](/claim/clm_CC58F9B2FE3A.md)
- 2009-07-31 to 2009-10-31 | money | shares_outstanding | 397,547,322 shares | superseded | [clm_CDF95198330D](/claim/clm_CDF95198330D.md)
- 2009-09-30 to 2009-12-31 | money | cash_and_equivalents | 960,300,000 United States dollar | superseded | [clm_846FE8113B18](/claim/clm_846FE8113B18.md)
- 2009-09-30 to 2010-03-31 | money | quarterly_net_income | 229,000,000 United States dollar | superseded | [clm_6FA66BDED22E](/claim/clm_6FA66BDED22E.md)
- 2009-09-30 to 2010-03-31 | money | quarterly_operating_income | 311,400,000 United States dollar | superseded | [clm_405256E3976D](/claim/clm_405256E3976D.md)
- 2009-09-30 to 2010-03-31 | money | quarterly_research_and_development | 83,700,000 United States dollar | superseded | [clm_4C296F1D3D42](/claim/clm_4C296F1D3D42.md)
- 2009-09-30 to 2010-03-31 | money | quarterly_revenue | 1,653,300,000 United States dollar | superseded | [clm_A36055955964](/claim/clm_A36055955964.md)
- 2009-09-30 to 2009-12-31 | money | total_assets | 8,459,200,000 United States dollar | superseded | [clm_F34DEB6BFAE6](/claim/clm_F34DEB6BFAE6.md)
- 2009-09-30 to 2009-12-31 | money | total_equity | 6,440,900,000 United States dollar | superseded | [clm_4049D2203338](/claim/clm_4049D2203338.md)
- 2009-10-31 to 2010-01-31 | money | shares_outstanding | 397,738,563 shares | superseded | [clm_6892602211C3](/claim/clm_6892602211C3.md)
- 2009-12-31 to 2010-03-31 | money | cash_and_equivalents | 658,700,000 United States dollar | superseded | [clm_743E7A9DCCFC](/claim/clm_743E7A9DCCFC.md)
- 2009-12-31 to 2010-12-31 | money | net_income | 1,107,400,000 United States dollar | superseded | [clm_EC17B9F0CE3D](/claim/clm_EC17B9F0CE3D.md)
- 2009-12-31 to 2010-12-31 | money | operating_income | 1,594,400,000 United States dollar | superseded | [clm_C28150582E16](/claim/clm_C28150582E16.md)
- 2009-12-31 to 2010-12-31 | money | research_and_development | 336,200,000 United States dollar | superseded | [clm_CCC592E32CE7](/claim/clm_CCC592E32CE7.md)
- 2009-12-31 to 2010-12-31 | money | revenue | 6,723,100,000 United States dollar | superseded | [clm_9D906633D7D7](/claim/clm_9D906633D7D7.md)
- 2009-12-31 to 2010-03-31 | money | total_assets | 9,071,300,000 United States dollar | superseded | [clm_906BE0D4F7FB](/claim/clm_906BE0D4F7FB.md)
- 2009-12-31 to 2010-03-31 | money | total_equity | 6,595,100,000 United States dollar | superseded | [clm_2E964C13FF0F](/claim/clm_2E964C13FF0F.md)

## 2010

- 2010-01-31 to 2010-03-31 | money | shares_outstanding | 398,051,370 shares | superseded | [clm_E2448CD4BFA2](/claim/clm_E2448CD4BFA2.md)
- 2010-03-31 to 2010-06-30 | money | cash_and_equivalents | 1,202,500,000 United States dollar | superseded | [clm_FD83B8699239](/claim/clm_FD83B8699239.md)
- 2010-03-31 to 2010-06-30 | money | quarterly_net_income | 321,700,000 United States dollar | superseded | [clm_3A644C92BA66](/claim/clm_3A644C92BA66.md)
- 2010-03-31 to 2010-06-30 | money | quarterly_operating_income | 446,400,000 United States dollar | superseded | [clm_2C7008B8AD14](/claim/clm_2C7008B8AD14.md)
- 2010-03-31 to 2010-06-30 | money | quarterly_research_and_development | 90,000,000 United States dollar | superseded | [clm_453589D6EA57](/claim/clm_453589D6EA57.md)
- 2010-03-31 to 2010-06-30 | money | quarterly_revenue | 1,799,100,000 United States dollar | superseded | [clm_A0ED8BED298A](/claim/clm_A0ED8BED298A.md)
- 2010-03-31 to 2010-07-31 | money | shares_outstanding | 396,698,933 shares | superseded | [clm_60F6C32EDB5A](/claim/clm_60F6C32EDB5A.md)
- 2010-03-31 to 2010-06-30 | money | total_assets | 10,098,400,000 United States dollar | superseded | [clm_79DB9D887661](/claim/clm_79DB9D887661.md)
- 2010-03-31 to 2010-06-30 | money | total_equity | 6,670,800,000 United States dollar | superseded | [clm_92CF0B698262](/claim/clm_92CF0B698262.md)
- 2010-06-30 to 2010-09-30 | money | cash_and_equivalents | 785,200,000 United States dollar | superseded | [clm_361E4D24E38B](/claim/clm_361E4D24E38B.md)
- 2010-06-30 to 2010-09-30 | money | quarterly_net_income | 319,000,000 United States dollar | superseded | [clm_64C06A49905A](/claim/clm_64C06A49905A.md)
- 2010-06-30 to 2010-09-30 | money | quarterly_operating_income | 448,100,000 United States dollar | superseded | [clm_E015B4F07E32](/claim/clm_E015B4F07E32.md)
- 2010-06-30 to 2010-09-30 | money | quarterly_research_and_development | 94,600,000 United States dollar | superseded | [clm_4242495E8AAB](/claim/clm_4242495E8AAB.md)
- 2010-06-30 to 2010-09-30 | money | quarterly_revenue | 1,758,200,000 United States dollar | superseded | [clm_CBC34D6436B5](/claim/clm_CBC34D6436B5.md)
- 2010-06-30 to 2010-09-30 | money | total_assets | 10,060,100,000 United States dollar | superseded | [clm_AEABF0C0A67C](/claim/clm_AEABF0C0A67C.md)
- 2010-06-30 to 2010-09-30 | money | total_equity | 6,745,500,000 United States dollar | superseded | [clm_8779E5EE9228](/claim/clm_8779E5EE9228.md)
- 2010-07-31 to 2010-10-31 | money | shares_outstanding | 396,940,168 shares | superseded | [clm_3AF4B0A47D26](/claim/clm_3AF4B0A47D26.md)
- 2010-09-30 to 2010-12-31 | money | cash_and_equivalents | 925,600,000 United States dollar | superseded | [clm_84F0F7B15DF7](/claim/clm_84F0F7B15DF7.md)
- 2010-09-30 to 2011-03-31 | money | quarterly_net_income | 337,700,000 United States dollar | superseded | [clm_DAD4EC978E32](/claim/clm_DAD4EC978E32.md)
- 2010-09-30 to 2011-03-31 | money | quarterly_operating_income | 470,500,000 United States dollar | superseded | [clm_F0F14E4257C6](/claim/clm_F0F14E4257C6.md)
- 2010-09-30 to 2011-03-31 | money | quarterly_research_and_development | 98,600,000 United States dollar | superseded | [clm_EAA78D9EE805](/claim/clm_EAA78D9EE805.md)
- 2010-09-30 to 2011-03-31 | money | quarterly_revenue | 1,767,600,000 United States dollar | superseded | [clm_B57E59613AD4](/claim/clm_B57E59613AD4.md)
- 2010-09-30 to 2010-12-31 | money | total_assets | 10,771,900,000 United States dollar | superseded | [clm_BBDF10422E57](/claim/clm_BBDF10422E57.md)
- 2010-09-30 to 2010-12-31 | money | total_equity | 7,306,000,000 United States dollar | superseded | [clm_3FD431872E64](/claim/clm_3FD431872E64.md)
- 2010-10-31 to 2011-01-31 | money | shares_outstanding | 397,120,134 shares | superseded | [clm_FA5DD9597DE6](/claim/clm_FA5DD9597DE6.md)
- 2010-12-31 to 2011-03-31 | money | cash_and_equivalents | 1,757,600,000 United States dollar | superseded | [clm_C4A50A3BE9AA](/claim/clm_C4A50A3BE9AA.md)
- 2010-12-31 to 2011-12-31 | money | net_income | 1,273,400,000 United States dollar | superseded | [clm_430593B08B13](/claim/clm_430593B08B13.md)
- 2010-12-31 to 2011-12-31 | money | operating_income | 1,751,400,000 United States dollar | superseded | [clm_52183107FA7C](/claim/clm_52183107FA7C.md)
- 2010-12-31 to 2011-12-31 | money | research_and_development | 393,900,000 United States dollar | superseded | [clm_09B4BCBF5BDF](/claim/clm_09B4BCBF5BDF.md)
- 2010-12-31 to 2011-12-31 | money | revenue | 7,320,000,000 United States dollar | superseded | [clm_771A4BAC2913](/claim/clm_771A4BAC2913.md)
- 2010-12-31 to 2011-03-31 | money | total_assets | 10,895,100,000 United States dollar | superseded | [clm_96109D869633](/claim/clm_96109D869633.md)
- 2010-12-31 to 2011-03-31 | money | total_equity | 7,173,600,000 United States dollar | superseded | [clm_FACB59F74ED1](/claim/clm_FACB59F74ED1.md)

## 2011

- 2011-01-31 to 2011-03-31 | money | shares_outstanding | 391,246,163 shares | superseded | [clm_58A5BD5E17B3](/claim/clm_58A5BD5E17B3.md)
- 2011-03-31 to 2011-06-30 | money | cash_and_equivalents | 735,100,000 United States dollar | superseded | [clm_0A3347E31839](/claim/clm_0A3347E31839.md)
- 2011-03-31 to 2011-06-30 | money | quarterly_net_income | 307,400,000 United States dollar | superseded | [clm_1A9692B88471](/claim/clm_1A9692B88471.md)
- 2011-03-31 to 2011-06-30 | money | quarterly_operating_income | 423,500,000 United States dollar | superseded | [clm_A6A0829FA05D](/claim/clm_A6A0829FA05D.md)
- 2011-03-31 to 2011-06-30 | money | quarterly_research_and_development | 110,900,000 United States dollar | superseded | [clm_ADE5E43F37CB](/claim/clm_ADE5E43F37CB.md)
- 2011-03-31 to 2011-06-30 | money | quarterly_revenue | 2,015,200,000 United States dollar | superseded | [clm_F35D40DE987D](/claim/clm_F35D40DE987D.md)
- 2011-03-31 to 2011-06-30 | money | shares_outstanding | 388,004,426 shares | superseded | [clm_F3B8ACB36B23](/claim/clm_F3B8ACB36B23.md)
- 2011-03-31 to 2011-06-30 | money | total_assets | 11,231,000,000 United States dollar | superseded | [clm_967835D91E83](/claim/clm_967835D91E83.md)
- 2011-03-31 to 2011-06-30 | money | total_equity | 7,452,400,000 United States dollar | superseded | [clm_EFE9BF5E6495](/claim/clm_EFE9BF5E6495.md)
- 2011-06-30 to 2011-09-30 | money | cash_and_equivalents | 497,100,000 United States dollar | superseded | [clm_682EB9E214DD](/claim/clm_682EB9E214DD.md)
- 2011-06-30 to 2011-09-30 | money | quarterly_net_income | 309,100,000 United States dollar | superseded | [clm_F67DD8E69C57](/claim/clm_F67DD8E69C57.md)
- 2011-06-30 to 2011-09-30 | money | quarterly_operating_income | 400,300,000 United States dollar | superseded | [clm_5951A87F24E4](/claim/clm_5951A87F24E4.md)
- 2011-06-30 to 2011-09-30 | money | quarterly_research_and_development | 114,500,000 United States dollar | superseded | [clm_3A176BA31294](/claim/clm_3A176BA31294.md)
- 2011-06-30 to 2011-09-30 | money | quarterly_revenue | 2,045,500,000 United States dollar | superseded | [clm_70E696D75E5B](/claim/clm_70E696D75E5B.md)
- 2011-06-30 to 2011-09-30 | money | shares_outstanding | 388,328,148 shares | superseded | [clm_6E2BB278FB92](/claim/clm_6E2BB278FB92.md)
- 2011-06-30 to 2011-09-30 | money | total_assets | 11,596,400,000 United States dollar | superseded | [clm_A57C916DC66A](/claim/clm_A57C916DC66A.md)
- 2011-06-30 to 2011-09-30 | money | total_equity | 7,778,000,000 United States dollar | superseded | [clm_3B3BD03A0714](/claim/clm_3B3BD03A0714.md)
- 2011-09-30 to 2011-12-31 | money | cash_and_equivalents | 810,000,000 United States dollar | superseded | [clm_36CC0FF01190](/claim/clm_36CC0FF01190.md)
- 2011-09-30 to 2012-03-31 | money | quarterly_net_income | 327,000,000 United States dollar | superseded | [clm_B8875971D994](/claim/clm_B8875971D994.md)
- 2011-09-30 to 2012-03-31 | money | quarterly_operating_income | 444,000,000 United States dollar | superseded | [clm_BD5A13494A0C](/claim/clm_BD5A13494A0C.md)
- 2011-09-30 to 2012-03-31 | money | quarterly_research_and_development | 122,000,000 United States dollar | superseded | [clm_FA99649C9BF5](/claim/clm_FA99649C9BF5.md)
- 2011-09-30 to 2012-03-31 | money | quarterly_revenue | 2,031,000,000 United States dollar | superseded | [clm_7BF3100E680A](/claim/clm_7BF3100E680A.md)
- 2011-09-30 to 2012-01-31 | money | shares_outstanding | 382,672,989 shares | superseded | [clm_F3B0E2E24AC7](/claim/clm_F3B0E2E24AC7.md)
- 2011-09-30 to 2011-12-31 | money | total_assets | 12,083,000,000 United States dollar | superseded | [clm_60F51ED74246](/claim/clm_60F51ED74246.md)
- 2011-09-30 to 2011-12-31 | money | total_equity | 7,557,000,000 United States dollar | superseded | [clm_E62840B73F10](/claim/clm_E62840B73F10.md)
- 2011-12-31 to 2012-03-31 | money | cash_and_equivalents | 905,000,000 United States dollar | superseded | [clm_D08481E691E3](/claim/clm_D08481E691E3.md)
- 2011-12-31 to 2012-12-31 | money | net_income | 1,345,000,000 United States dollar | superseded | [clm_879B591A6BB5](/claim/clm_879B591A6BB5.md)
- 2011-12-31 to 2012-12-31 | money | operating_income | 1,686,000,000 United States dollar | superseded | [clm_74CADB71F483](/claim/clm_74CADB71F483.md)
- 2011-12-31 to 2012-12-31 | money | research_and_development | 462,000,000 United States dollar | superseded | [clm_8F1E9988ED59](/claim/clm_8F1E9988ED59.md)
- 2011-12-31 to 2012-12-31 | money | revenue | 8,307,000,000 United States dollar | superseded | [clm_714A512C3517](/claim/clm_714A512C3517.md)
- 2011-12-31 to 2012-03-31 | money | total_assets | 12,405,000,000 United States dollar | superseded | [clm_5E780776CA8E](/claim/clm_5E780776CA8E.md)
- 2011-12-31 to 2012-03-31 | money | total_equity | 7,683,000,000 United States dollar | superseded | [clm_0A8110B489E2](/claim/clm_0A8110B489E2.md)

## 2012

- 2012-01-31 to 2012-03-31 | money | shares_outstanding | 381,020,053 shares | superseded | [clm_3ECBF016602B](/claim/clm_3ECBF016602B.md)
- 2012-03-31 to 2012-06-30 | money | cash_and_equivalents | 690,000,000 United States dollar | superseded | [clm_831B20C0389A](/claim/clm_831B20C0389A.md)
- 2012-03-31 to 2012-06-30 | money | quarterly_net_income | 350,000,000 United States dollar | superseded | [clm_5F4FAEB970E7](/claim/clm_5F4FAEB970E7.md)
- 2012-03-31 to 2012-06-30 | money | quarterly_operating_income | 476,000,000 United States dollar | superseded | [clm_97FB6B006D98](/claim/clm_97FB6B006D98.md)
- 2012-03-31 to 2012-06-30 | money | quarterly_research_and_development | 112,000,000 United States dollar | superseded | [clm_F327EBF7C231](/claim/clm_F327EBF7C231.md)
- 2012-03-31 to 2012-06-30 | money | quarterly_revenue | 2,161,000,000 United States dollar | superseded | [clm_28521A6633DC](/claim/clm_28521A6633DC.md)
- 2012-03-31 to 2012-06-30 | money | shares_outstanding | 380,933,033 shares | superseded | [clm_0439467E001A](/claim/clm_0439467E001A.md)
- 2012-03-31 to 2012-06-30 | money | total_assets | 12,459,000,000 United States dollar | superseded | [clm_395EAF6CEA9A](/claim/clm_395EAF6CEA9A.md)
- 2012-03-31 to 2012-06-30 | money | total_equity | 8,022,000,000 United States dollar | superseded | [clm_04BB91B99CBE](/claim/clm_04BB91B99CBE.md)
- 2012-06-30 to 2012-09-30 | money | cash_and_equivalents | 1,393,000,000 United States dollar | superseded | [clm_B24FCC5CA797](/claim/clm_B24FCC5CA797.md)
- 2012-06-30 to 2012-09-30 | money | quarterly_net_income | 325,000,000 United States dollar | superseded | [clm_32DC13323231](/claim/clm_32DC13323231.md)
- 2012-06-30 to 2012-09-30 | money | quarterly_operating_income | 445,000,000 United States dollar | superseded | [clm_654DA8C72539](/claim/clm_654DA8C72539.md)
- 2012-06-30 to 2012-09-30 | money | quarterly_research_and_development | 116,000,000 United States dollar | superseded | [clm_49EFD328D4FB](/claim/clm_49EFD328D4FB.md)
- 2012-06-30 to 2012-09-30 | money | quarterly_revenue | 2,106,000,000 United States dollar | superseded | [clm_6E493FD75232](/claim/clm_6E493FD75232.md)
- 2012-06-30 to 2012-09-30 | money | shares_outstanding | 380,444,166 shares | superseded | [clm_9F4F92C48449](/claim/clm_9F4F92C48449.md)
- 2012-06-30 to 2012-09-30 | money | total_assets | 12,262,000,000 United States dollar | superseded | [clm_46C754610144](/claim/clm_46C754610144.md)
- 2012-06-30 to 2012-09-30 | money | total_equity | 7,952,000,000 United States dollar | superseded | [clm_FEFEA1C75886](/claim/clm_FEFEA1C75886.md)
- 2012-09-30 to 2012-12-31 | money | cash_and_equivalents | 1,423,000,000 United States dollar | superseded | [clm_016C59371F56](/claim/clm_016C59371F56.md)
- 2012-09-30 to 2013-03-31 | money | quarterly_net_income | 353,000,000 United States dollar | superseded | [clm_4999CDFED899](/claim/clm_4999CDFED899.md)
- 2012-09-30 to 2013-03-31 | money | quarterly_operating_income | 450,000,000 United States dollar | superseded | [clm_3E7FA3DA7383](/claim/clm_3E7FA3DA7383.md)
- 2012-09-30 to 2013-03-31 | money | quarterly_research_and_development | 114,000,000 United States dollar | superseded | [clm_D5B6EF211FA1](/claim/clm_D5B6EF211FA1.md)
- 2012-09-30 to 2013-03-31 | money | quarterly_revenue | 2,052,000,000 United States dollar | superseded | [clm_373662D6C03E](/claim/clm_373662D6C03E.md)
- 2012-09-30 to 2013-01-31 | money | shares_outstanding | 380,200,593 shares | superseded | [clm_98831619F4EE](/claim/clm_98831619F4EE.md)
- 2012-09-30 to 2012-12-31 | money | total_assets | 12,777,000,000 United States dollar | superseded | [clm_3DF6FF4559C7](/claim/clm_3DF6FF4559C7.md)
- 2012-09-30 to 2012-12-31 | money | total_equity | 8,361,000,000 United States dollar | superseded | [clm_B393BDC97C4C](/claim/clm_B393BDC97C4C.md)
- 2012-12-31 to 2013-03-31 | money | cash_and_equivalents | 1,395,000,000 United States dollar | superseded | [clm_FF30A5FB9645](/claim/clm_FF30A5FB9645.md)
- 2012-12-31 to 2013-12-31 | money | net_income | 1,298,000,000 United States dollar | superseded | [clm_A9E62A4E7C2C](/claim/clm_A9E62A4E7C2C.md)
- 2012-12-31 to 2013-12-31 | money | operating_income | 1,741,000,000 United States dollar | superseded | [clm_B2E688395FA4](/claim/clm_B2E688395FA4.md)
- 2012-12-31 to 2013-12-31 | money | research_and_development | 471,000,000 United States dollar | superseded | [clm_4467B6A8185C](/claim/clm_4467B6A8185C.md)
- 2012-12-31 to 2013-12-31 | money | revenue | 8,657,000,000 United States dollar | superseded | [clm_374CE38BDCDA](/claim/clm_374CE38BDCDA.md)
- 2012-12-31 to 2013-03-31 | money | total_assets | 13,206,000,000 United States dollar | superseded | [clm_931E974CEAA8](/claim/clm_931E974CEAA8.md)
- 2012-12-31 to 2013-03-31 | money | total_equity | 8,597,000,000 United States dollar | superseded | [clm_3061458A89D7](/claim/clm_3061458A89D7.md)

## 2013

- 2013-01-31 to 2013-03-31 | money | shares_outstanding | 380,512,172 shares | superseded | [clm_EFA405775A90](/claim/clm_EFA405775A90.md)
- 2013-03-31 to 2013-06-30 | money | cash_and_equivalents | 1,913,000,000 United States dollar | superseded | [clm_1AC19489738E](/claim/clm_1AC19489738E.md)
- 2013-03-31 to 2013-06-30 | money | quarterly_net_income | 304,000,000 United States dollar | superseded | [clm_9F7D87082672](/claim/clm_9F7D87082672.md)
- 2013-03-31 to 2013-06-30 | money | quarterly_operating_income | 386,000,000 United States dollar | superseded | [clm_10E321D9598C](/claim/clm_10E321D9598C.md)
- 2013-03-31 to 2013-06-30 | money | quarterly_research_and_development | 129,000,000 United States dollar | superseded | [clm_4BFC9C378319](/claim/clm_4BFC9C378319.md)
- 2013-03-31 to 2013-06-30 | money | quarterly_revenue | 2,190,000,000 United States dollar | superseded | [clm_57431BE95E2D](/claim/clm_57431BE95E2D.md)
- 2013-03-31 to 2013-06-30 | money | shares_outstanding | 378,056,811 shares | superseded | [clm_2436FFED5F71](/claim/clm_2436FFED5F71.md)
- 2013-03-31 to 2013-06-30 | money | total_assets | 14,089,000,000 United States dollar | superseded | [clm_70BBF48F0D04](/claim/clm_70BBF48F0D04.md)
- 2013-03-31 to 2013-06-30 | money | total_equity | 8,456,000,000 United States dollar | superseded | [clm_8761E9B8A37D](/claim/clm_8761E9B8A37D.md)
- 2013-06-30 to 2013-09-30 | money | cash_and_equivalents | 971,000,000 United States dollar | superseded | [clm_BA4F42CE6FEC](/claim/clm_BA4F42CE6FEC.md)
- 2013-06-30 to 2013-09-30 | money | quarterly_net_income | 213,000,000 United States dollar | superseded | [clm_C93D425C0802](/claim/clm_C93D425C0802.md)
- 2013-06-30 to 2013-09-30 | money | quarterly_operating_income | 290,000,000 United States dollar | superseded | [clm_013FCF89EAEE](/claim/clm_013FCF89EAEE.md)
- 2013-06-30 to 2013-09-30 | money | quarterly_research_and_development | 132,000,000 United States dollar | superseded | [clm_2919511E9B5F](/claim/clm_2919511E9B5F.md)
- 2013-06-30 to 2013-09-30 | money | quarterly_revenue | 2,212,000,000 United States dollar | superseded | [clm_6B6F1202F4D9](/claim/clm_6B6F1202F4D9.md)
- 2013-06-30 to 2013-09-30 | money | shares_outstanding | 378,132,187 shares | superseded | [clm_DBF425D6DEB1](/claim/clm_DBF425D6DEB1.md)
- 2013-06-30 to 2013-09-30 | money | total_assets | 14,382,000,000 United States dollar | superseded | [clm_E9B2E55F410C](/claim/clm_E9B2E55F410C.md)
- 2013-06-30 to 2013-09-30 | money | total_equity | 8,603,000,000 United States dollar | superseded | [clm_0A6A6FB04522](/claim/clm_0A6A6FB04522.md)
- 2013-09-30 to 2013-12-31 | money | cash_and_equivalents | 1,110,000,000 United States dollar | superseded | [clm_2654F5071578](/claim/clm_2654F5071578.md)
- 2013-09-30 to 2014-03-31 | money | quarterly_net_income | 103,000,000 United States dollar | superseded | [clm_4B18581C9B70](/claim/clm_4B18581C9B70.md)
- 2013-09-30 to 2014-03-31 | money | quarterly_operating_income | 150,000,000 United States dollar | superseded | [clm_77255FEAEA2C](/claim/clm_77255FEAEA2C.md)
- 2013-09-30 to 2014-03-31 | money | quarterly_research_and_development | 136,000,000 United States dollar | superseded | [clm_63E0B610D53F](/claim/clm_63E0B610D53F.md)
- 2013-09-30 to 2014-03-31 | money | quarterly_revenue | 2,151,000,000 United States dollar | superseded | [clm_80B3B207ABF2](/claim/clm_80B3B207ABF2.md)
- 2013-09-30 to 2014-01-31 | money | shares_outstanding | 378,418,945 shares | superseded | [clm_4E7BF3E65865](/claim/clm_4E7BF3E65865.md)
- 2013-09-30 to 2013-12-31 | money | total_assets | 14,883,000,000 United States dollar | superseded | [clm_64FDF922921A](/claim/clm_64FDF922921A.md)
- 2013-09-30 to 2013-12-31 | money | total_equity | 8,737,000,000 United States dollar | superseded | [clm_52D4B9A2F2FF](/claim/clm_52D4B9A2F2FF.md)
- 2013-12-31 to 2014-03-31 | money | cash_and_equivalents | 1,339,000,000 United States dollar | superseded | [clm_9C31AEC61C38](/claim/clm_9C31AEC61C38.md)
- 2013-12-31 to 2014-12-31 | money | net_income | 1,006,000,000 United States dollar | superseded | [clm_1D5DEC2D7593](/claim/clm_1D5DEC2D7593.md)
- 2013-12-31 to 2014-12-31 | money | operating_income | 1,256,000,000 United States dollar | superseded | [clm_9A2884161643](/claim/clm_9A2884161643.md)
- 2013-12-31 to 2014-12-31 | money | research_and_development | 536,000,000 United States dollar | superseded | [clm_39946B205064](/claim/clm_39946B205064.md)
- 2013-12-31 to 2014-12-31 | money | revenue | 9,021,000,000 United States dollar | superseded | [clm_F46DC701B5F0](/claim/clm_F46DC701B5F0.md)
- 2013-12-31 to 2014-03-31 | money | total_assets | 15,743,000,000 United States dollar | superseded | [clm_CDFFEAD60560](/claim/clm_CDFFEAD60560.md)
- 2013-12-31 to 2014-03-31 | money | total_equity | 9,047,000,000 United States dollar | superseded | [clm_6D594018C9EB](/claim/clm_6D594018C9EB.md)

## 2014

- 2014-01-31 to 2014-03-31 | money | shares_outstanding | 377,870,936 shares | superseded | [clm_422DD1E8A85E](/claim/clm_422DD1E8A85E.md)
- 2014-03-31 to 2014-06-30 | money | cash_and_equivalents | 1,381,000,000 United States dollar | superseded | [clm_C1DF025982E9](/claim/clm_C1DF025982E9.md)
- 2014-03-31 to 2014-06-30 | money | quarterly_net_income | 70,000,000 United States dollar | superseded | [clm_B025D18AE8DA](/claim/clm_B025D18AE8DA.md)
- 2014-03-31 to 2014-06-30 | money | quarterly_operating_income | 131,000,000 United States dollar | superseded | [clm_B54E5928AFD2](/claim/clm_B54E5928AFD2.md)
- 2014-03-31 to 2014-06-30 | money | quarterly_research_and_development | 150,000,000 United States dollar | superseded | [clm_ACABC04C52F6](/claim/clm_ACABC04C52F6.md)
- 2014-03-31 to 2014-06-30 | money | quarterly_revenue | 2,305,000,000 United States dollar | superseded | [clm_2B0A94066848](/claim/clm_2B0A94066848.md)
- 2014-03-31 to 2014-06-30 | money | shares_outstanding | 379,093,934 shares | superseded | [clm_610015486BC4](/claim/clm_610015486BC4.md)
- 2014-03-31 to 2014-06-30 | money | total_assets | 16,159,000,000 United States dollar | superseded | [clm_5D5C4746CF27](/claim/clm_5D5C4746CF27.md)
- 2014-03-31 to 2014-06-30 | money | total_equity | 9,063,000,000 United States dollar | superseded | [clm_62D65678F1E5](/claim/clm_62D65678F1E5.md)
- 2014-06-30 to 2014-09-30 | money | cash_and_equivalents | 1,319,000,000 United States dollar | superseded | [clm_381AF081AEF4](/claim/clm_381AF081AEF4.md)
- 2014-06-30 to 2014-09-30 | money | quarterly_net_income | 128,000,000 United States dollar | superseded | [clm_000897C65CD1](/claim/clm_000897C65CD1.md)
- 2014-06-30 to 2014-09-30 | money | quarterly_operating_income | 197,000,000 United States dollar | superseded | [clm_A6067C5557FE](/claim/clm_A6067C5557FE.md)
- 2014-06-30 to 2014-09-30 | money | quarterly_research_and_development | 158,000,000 United States dollar | superseded | [clm_FE5AAE871498](/claim/clm_FE5AAE871498.md)
- 2014-06-30 to 2014-09-30 | money | quarterly_revenue | 2,363,000,000 United States dollar | superseded | [clm_D3216AB26C45](/claim/clm_D3216AB26C45.md)
- 2014-06-30 to 2014-09-30 | money | shares_outstanding | 378,582,992 shares | superseded | [clm_F8CB558773CC](/claim/clm_F8CB558773CC.md)
- 2014-06-30 to 2014-09-30 | money | total_assets | 17,229,000,000 United States dollar | superseded | [clm_68D719844FD4](/claim/clm_68D719844FD4.md)
- 2014-06-30 to 2014-09-30 | money | total_equity | 9,002,000,000 United States dollar | superseded | [clm_A5E40A424572](/claim/clm_A5E40A424572.md)
- 2014-09-30 to 2014-12-31 | money | cash_and_equivalents | 1,356,000,000 United States dollar | superseded | [clm_BBF774311AE2](/claim/clm_BBF774311AE2.md)
- 2014-09-30 to 2015-03-31 | money | quarterly_net_income | 57,000,000 United States dollar | superseded | [clm_198E88F06555](/claim/clm_198E88F06555.md)
- 2014-09-30 to 2015-03-31 | money | quarterly_operating_income | 450,000,000 United States dollar | superseded | [clm_ECA984DFDF21](/claim/clm_ECA984DFDF21.md)
- 2014-09-30 to 2015-03-31 | money | quarterly_research_and_development | 153,000,000 United States dollar | superseded | [clm_0E6450F66A56](/claim/clm_0E6450F66A56.md)
- 2014-09-30 to 2015-03-31 | money | quarterly_revenue | 2,389,000,000 United States dollar | superseded | [clm_56EDE77D2F7D](/claim/clm_56EDE77D2F7D.md)
- 2014-09-30 to 2015-01-31 | money | shares_outstanding | 378,320,513 shares | superseded | [clm_0DA235638A1E](/claim/clm_0DA235638A1E.md)
- 2014-09-30 to 2014-12-31 | money | total_assets | 17,515,000,000 United States dollar | superseded | [clm_44E88EDF2E6B](/claim/clm_44E88EDF2E6B.md)
- 2014-09-30 to 2014-12-31 | money | total_equity | 8,624,000,000 United States dollar | superseded | [clm_86208FBC7B21](/claim/clm_86208FBC7B21.md)
- 2014-12-31 to 2015-03-31 | money | cash_and_equivalents | 1,795,000,000 United States dollar | superseded | [clm_07B4C3BAA73E](/claim/clm_07B4C3BAA73E.md)
- 2014-12-31 to 2015-12-31 | money | net_income | 515,000,000 United States dollar | superseded | [clm_AE2E7B64D17E](/claim/clm_AE2E7B64D17E.md)
- 2014-12-31 to 2015-12-31 | money | operating_income | 1,246,000,000 United States dollar | superseded | [clm_8BC108433968](/claim/clm_8BC108433968.md)
- 2014-12-31 to 2015-12-31 | money | research_and_development | 614,000,000 United States dollar | superseded | [clm_201FD7A30A4D](/claim/clm_201FD7A30A4D.md)
- 2014-12-31 to 2015-12-31 | money | revenue | 9,675,000,000 United States dollar | superseded | [clm_3DE9D6D92348](/claim/clm_3DE9D6D92348.md)
- 2014-12-31 to 2015-03-31 | money | total_assets | 17,713,000,000 United States dollar | superseded | [clm_D7AFF104A930](/claim/clm_D7AFF104A930.md)
- 2014-12-31 to 2015-03-31 | money | total_equity | 8,595,000,000 United States dollar | superseded | [clm_09A9AE8E0E0C](/claim/clm_09A9AE8E0E0C.md)

## 2015

- 2015-01-31 to 2015-03-31 | money | shares_outstanding | 378,749,951 shares | superseded | [clm_CA3C69B3E053](/claim/clm_CA3C69B3E053.md)
- 2015-03-31 to 2015-06-30 | money | cash_and_equivalents | 1,674,000,000 United States dollar | superseded | [clm_4374CD94318E](/claim/clm_4374CD94318E.md)
- 2015-03-31 to 2015-06-30 | money | quarterly_net_income | 224,000,000 United States dollar | superseded | [clm_787A7E62117C](/claim/clm_787A7E62117C.md)
- 2015-03-31 to 2015-06-30 | money | quarterly_operating_income | 406,000,000 United States dollar | superseded | [clm_2CAB2726C660](/claim/clm_2CAB2726C660.md)
- 2015-03-31 to 2015-06-30 | money | quarterly_research_and_development | 152,000,000 United States dollar | superseded | [clm_9793D499B9D0](/claim/clm_9793D499B9D0.md)
- 2015-03-31 to 2015-06-30 | money | quarterly_revenue | 2,379,000,000 United States dollar | superseded | [clm_8EBC6A8C2421](/claim/clm_8EBC6A8C2421.md)
- 2015-03-31 to 2015-06-30 | money | shares_outstanding | 378,409,144 shares | superseded | [clm_3E41D88534B4](/claim/clm_3E41D88534B4.md)
- 2015-03-31 to 2015-06-30 | money | total_assets | 16,580,000,000 United States dollar | superseded | [clm_36B64A6B59F8](/claim/clm_36B64A6B59F8.md)
- 2015-03-31 to 2015-06-30 | money | total_equity | 8,321,000,000 United States dollar | superseded | [clm_A745B4A3EDF7](/claim/clm_A745B4A3EDF7.md)
- 2015-06-30 to 2015-09-30 | money | cash_and_equivalents | 3,626,000,000 United States dollar | superseded | [clm_DAF2722CC80F](/claim/clm_DAF2722CC80F.md)
- 2015-06-30 to 2015-09-30 | money | quarterly_net_income | 392,000,000 United States dollar | superseded | [clm_60A576B8E704](/claim/clm_60A576B8E704.md)
- 2015-06-30 to 2015-09-30 | money | quarterly_operating_income | 429,000,000 United States dollar | superseded | [clm_1645661E6806](/claim/clm_1645661E6806.md)
- 2015-06-30 to 2015-09-30 | money | quarterly_research_and_development | 154,000,000 United States dollar | superseded | [clm_BEB9661394D0](/claim/clm_BEB9661394D0.md)
- 2015-06-30 to 2015-09-30 | money | quarterly_revenue | 2,432,000,000 United States dollar | superseded | [clm_BF4469A366D7](/claim/clm_BF4469A366D7.md)
- 2015-06-30 to 2015-09-30 | money | shares_outstanding | 376,558,214 shares | superseded | [clm_8919BDA9CE99](/claim/clm_8919BDA9CE99.md)
- 2015-06-30 to 2015-09-30 | money | total_assets | 16,819,000,000 United States dollar | superseded | [clm_09EA23E3ED9B](/claim/clm_09EA23E3ED9B.md)
- 2015-06-30 to 2015-09-30 | money | total_equity | 8,505,000,000 United States dollar | superseded | [clm_6040B1D3A809](/claim/clm_6040B1D3A809.md)
- 2015-09-30 to 2015-12-31 | money | cash_and_equivalents | 3,163,000,000 United States dollar | superseded | [clm_2710B4627E53](/claim/clm_2710B4627E53.md)
- 2015-09-30 to 2016-03-31 | money | quarterly_net_income | 301,000,000 United States dollar | superseded | [clm_7A45C6D22A4A](/claim/clm_7A45C6D22A4A.md)
- 2015-09-30 to 2016-03-31 | money | quarterly_operating_income | 378,000,000 United States dollar | superseded | [clm_C85B73F3E385](/claim/clm_C85B73F3E385.md)
- 2015-09-30 to 2016-03-31 | money | quarterly_research_and_development | 155,000,000 United States dollar | superseded | [clm_92E79C824790](/claim/clm_92E79C824790.md)
- 2015-09-30 to 2016-03-31 | money | quarterly_revenue | 2,420,000,000 United States dollar | superseded | [clm_052BEB810912](/claim/clm_052BEB810912.md)
- 2015-09-30 to 2016-01-31 | money | shares_outstanding | 375,522,232 shares | superseded | [clm_CA7CC5A51A54](/claim/clm_CA7CC5A51A54.md)
- 2015-09-30 to 2015-12-31 | money | total_assets | 15,917,000,000 United States dollar | superseded | [clm_1BC06C67E514](/claim/clm_1BC06C67E514.md)
- 2015-09-30 to 2015-12-31 | money | total_equity | 8,484,000,000 United States dollar | superseded | [clm_7DACB729FE50](/claim/clm_7DACB729FE50.md)
- 2015-12-31 to 2016-03-31 | money | cash_and_equivalents | 3,379,000,000 United States dollar | superseded | [clm_6A9778D5707D](/claim/clm_6A9778D5707D.md)
- 2015-12-31 to 2016-12-31 | money | net_income | 1,439,000,000 United States dollar | superseded | [clm_F7DE11BA1021](/claim/clm_F7DE11BA1021.md)
- 2015-12-31 to 2016-12-31 | money | operating_income | 1,861,000,000 United States dollar | superseded | [clm_D1CA23FA65BA](/claim/clm_D1CA23FA65BA.md)
- 2015-12-31 to 2016-12-31 | money | research_and_development | 625,000,000 United States dollar | superseded | [clm_B2943EF01993](/claim/clm_B2943EF01993.md)
- 2015-12-31 to 2016-12-31 | money | revenue | 9,946,000,000 United States dollar | superseded | [clm_16BDD523EAD1](/claim/clm_16BDD523EAD1.md)
- 2015-12-31 to 2016-03-31 | money | total_assets | 16,247,000,000 United States dollar | superseded | [clm_32C402698FB6](/claim/clm_32C402698FB6.md)
- 2015-12-31 to 2016-03-31 | money | total_equity | 8,511,000,000 United States dollar | superseded | [clm_A00FB1634E83](/claim/clm_A00FB1634E83.md)

## 2016

- 2016-01-31 to 2016-03-31 | money | shares_outstanding | 372,982,213 shares | superseded | [clm_9F390A54C7F5](/claim/clm_9F390A54C7F5.md)
- 2016-03-31 to 2016-06-30 | money | cash_and_equivalents | 6,976,000,000 United States dollar | superseded | [clm_0871F7FD189D](/claim/clm_0871F7FD189D.md)
- 2016-03-31 to 2016-06-30 | money | quarterly_net_income | 402,000,000 United States dollar | superseded | [clm_733F282C5241](/claim/clm_733F282C5241.md)
- 2016-03-31 to 2016-06-30 | money | quarterly_operating_income | 519,000,000 United States dollar | superseded | [clm_1302D9D97099](/claim/clm_1302D9D97099.md)
- 2016-03-31 to 2016-06-30 | money | quarterly_research_and_development | 159,000,000 United States dollar | superseded | [clm_2CE52D974E05](/claim/clm_2CE52D974E05.md)
- 2016-03-31 to 2016-06-30 | money | quarterly_revenue | 2,495,000,000 United States dollar | superseded | [clm_A136A033A101](/claim/clm_A136A033A101.md)
- 2016-03-31 to 2016-06-30 | money | shares_outstanding | 373,981,097 shares | superseded | [clm_CEB380DE69E5](/claim/clm_CEB380DE69E5.md)
- 2016-03-31 to 2016-06-30 | money | total_assets | 19,668,000,000 United States dollar | superseded | [clm_50BF0E1CD1C0](/claim/clm_50BF0E1CD1C0.md)
- 2016-03-31 to 2016-06-30 | money | total_equity | 8,808,000,000 United States dollar | superseded | [clm_2CDDE2F0211A](/claim/clm_2CDDE2F0211A.md)
- 2016-06-30 to 2016-09-30 | money | cash_and_equivalents | 3,490,000,000 United States dollar | superseded | [clm_52A99F40BF80](/claim/clm_52A99F40BF80.md)
- 2016-06-30 to 2016-09-30 | money | quarterly_net_income | 380,000,000 United States dollar | superseded | [clm_955DEE6DFF5B](/claim/clm_955DEE6DFF5B.md)
- 2016-06-30 to 2016-09-30 | money | quarterly_operating_income | 500,000,000 United States dollar | superseded | [clm_10BD43968A49](/claim/clm_10BD43968A49.md)
- 2016-06-30 to 2016-09-30 | money | quarterly_research_and_development | 183,000,000 United States dollar | superseded | [clm_B645460D7601](/claim/clm_B645460D7601.md)
- 2016-06-30 to 2016-09-30 | money | quarterly_revenue | 2,840,000,000 United States dollar | superseded | [clm_493669E0305E](/claim/clm_493669E0305E.md)
- 2016-06-30 to 2016-09-30 | money | shares_outstanding | 374,302,065 shares | superseded | [clm_701B83A4A7FC](/claim/clm_701B83A4A7FC.md)
- 2016-06-30 to 2016-09-30 | money | total_assets | 20,520,000,000 United States dollar | superseded | [clm_5C7BDBEA0D9B](/claim/clm_5C7BDBEA0D9B.md)
- 2016-06-30 to 2016-09-30 | money | total_equity | 9,098,000,000 United States dollar | superseded | [clm_E5A8D70F2FF4](/claim/clm_E5A8D70F2FF4.md)
- 2016-09-30 to 2016-12-31 | money | cash_and_equivalents | 2,953,000,000 United States dollar | superseded | [clm_15BC8332EE1A](/claim/clm_15BC8332EE1A.md)
- 2016-09-30 to 2017-03-31 | money | quarterly_net_income | 355,000,000 United States dollar | superseded | [clm_CCBD317F41D5](/claim/clm_CCBD317F41D5.md)
- 2016-09-30 to 2017-03-31 | money | quarterly_operating_income | 486,000,000 United States dollar | superseded | [clm_69AAD42C607B](/claim/clm_69AAD42C607B.md)
- 2016-09-30 to 2017-03-31 | money | quarterly_research_and_development | 184,000,000 United States dollar | superseded | [clm_AE2D35E2BF13](/claim/clm_AE2D35E2BF13.md)
- 2016-09-30 to 2017-03-31 | money | quarterly_revenue | 2,833,000,000 United States dollar | superseded | [clm_0DC7620FE21A](/claim/clm_0DC7620FE21A.md)
- 2016-09-30 to 2017-01-31 | money | shares_outstanding | 374,451,718 shares | superseded | [clm_D978BA6E96DB](/claim/clm_D978BA6E96DB.md)
- 2016-09-30 to 2016-12-31 | money | total_assets | 20,187,000,000 United States dollar | superseded | [clm_203A9967F9E6](/claim/clm_203A9967F9E6.md)
- 2016-09-30 to 2016-12-31 | money | total_equity | 9,332,000,000 United States dollar | superseded | [clm_A524BD28C56B](/claim/clm_A524BD28C56B.md)
- 2016-12-31 to 2017-03-31 | money | cash_and_equivalents | 3,316,000,000 United States dollar | superseded | [clm_39B59A4EFDC5](/claim/clm_39B59A4EFDC5.md)
- 2016-12-31 to 2017-12-31 | money | net_income | 1,647,000,000 United States dollar | superseded | [clm_D29CFA69B8E7](/claim/clm_D29CFA69B8E7.md)
- 2016-12-31 to 2017-12-31 | money | operating_income | 2,166,000,000 United States dollar | superseded | [clm_E8D0D786058E](/claim/clm_E8D0D786058E.md)
- 2016-12-31 to 2017-12-31 | money | research_and_development | 715,000,000 United States dollar | superseded | [clm_0801EE9677F8](/claim/clm_0801EE9677F8.md)
- 2016-12-31 to 2017-12-31 | money | revenue | 11,325,000,000 United States dollar | superseded | [clm_58F84D197D5C](/claim/clm_58F84D197D5C.md)
- 2016-12-31 to 2017-03-31 | money | total_assets | 20,435,000,000 United States dollar | superseded | [clm_ECF273ED40DE](/claim/clm_ECF273ED40DE.md)
- 2016-12-31 to 2017-03-31 | money | total_equity | 9,550,000,000 United States dollar | superseded | [clm_4437646C3CA3](/claim/clm_4437646C3CA3.md)

## 2017

- 2017-01-31 to 2017-03-31 | money | shares_outstanding | 372,878,298 shares | superseded | [clm_EA5A297266CF](/claim/clm_EA5A297266CF.md)
- 2017-03-31 to 2017-06-30 | money | cash_and_equivalents | 3,213,000,000 United States dollar | superseded | [clm_C48CEE54DDD9](/claim/clm_C48CEE54DDD9.md)
- 2017-03-31 to 2017-06-30 | money | quarterly_net_income | 444,000,000 United States dollar | superseded | [clm_3AD239BC34C0](/claim/clm_3AD239BC34C0.md)
- 2017-03-31 to 2017-06-30 | money | quarterly_operating_income | 554,000,000 United States dollar | superseded | [clm_7A6E49883616](/claim/clm_7A6E49883616.md)
- 2017-03-31 to 2017-06-30 | money | quarterly_research_and_development | 192,000,000 United States dollar | superseded | [clm_D96D0580D8AE](/claim/clm_D96D0580D8AE.md)
- 2017-03-31 to 2017-06-30 | money | quarterly_revenue | 2,955,000,000 United States dollar | superseded | [clm_E1E5ACA01AA8](/claim/clm_E1E5ACA01AA8.md)
- 2017-03-31 to 2017-06-30 | money | shares_outstanding | 373,765,028 shares | superseded | [clm_0996F2BEA8A0](/claim/clm_0996F2BEA8A0.md)
- 2017-03-31 to 2017-06-30 | money | total_assets | 20,517,000,000 United States dollar | superseded | [clm_CFF879E402FC](/claim/clm_CFF879E402FC.md)
- 2017-03-31 to 2017-06-30 | money | total_equity | 9,704,000,000 United States dollar | superseded | [clm_B8FF9A76AD06](/claim/clm_B8FF9A76AD06.md)
- 2017-06-30 to 2017-09-30 | money | cash_and_equivalents | 3,649,000,000 United States dollar | superseded | [clm_596DA70D2728](/claim/clm_596DA70D2728.md)
- 2017-06-30 to 2017-09-30 | money | quarterly_net_income | 391,000,000 United States dollar | superseded | [clm_055D092DC8C5](/claim/clm_055D092DC8C5.md)
- 2017-06-30 to 2017-09-30 | money | quarterly_operating_income | 501,000,000 United States dollar | superseded | [clm_E51FAE9170BB](/claim/clm_E51FAE9170BB.md)
- 2017-06-30 to 2017-09-30 | money | quarterly_research_and_development | 192,000,000 United States dollar | superseded | [clm_594FA442E545](/claim/clm_594FA442E545.md)
- 2017-06-30 to 2017-09-30 | money | quarterly_revenue | 3,012,000,000 United States dollar | superseded | [clm_B5F9D8DF2B89](/claim/clm_B5F9D8DF2B89.md)
- 2017-06-30 to 2017-09-30 | money | shares_outstanding | 374,063,294 shares | superseded | [clm_B949C2573D52](/claim/clm_B949C2573D52.md)
- 2017-06-30 to 2017-09-30 | money | total_assets | 21,292,000,000 United States dollar | superseded | [clm_F3475369B4F0](/claim/clm_F3475369B4F0.md)
- 2017-06-30 to 2017-09-30 | money | total_equity | 10,035,000,000 United States dollar | superseded | [clm_8CD419311E75](/claim/clm_8CD419311E75.md)
- 2017-09-30 to 2017-12-31 | money | cash_and_equivalents | 2,592,000,000 United States dollar | superseded | [clm_0C15D130D6E0](/claim/clm_0C15D130D6E0.md)
- 2017-09-30 to 2018-03-31 | money | quarterly_net_income | 434,000,000 United States dollar | superseded | [clm_466868801F25](/claim/clm_466868801F25.md)
- 2017-09-30 to 2018-03-31 | money | quarterly_operating_income | 523,000,000 United States dollar | superseded | [clm_81A618C4C94F](/claim/clm_81A618C4C94F.md)
- 2017-09-30 to 2018-03-31 | money | quarterly_research_and_development | 198,000,000 United States dollar | superseded | [clm_CC654750CF9D](/claim/clm_CC654750CF9D.md)
- 2017-09-30 to 2018-03-31 | money | quarterly_revenue | 3,006,000,000 United States dollar | superseded | [clm_A759926B3451](/claim/clm_A759926B3451.md)
- 2017-09-30 to 2018-01-31 | money | shares_outstanding | 374,237,631 shares | superseded | [clm_510DA84D7642](/claim/clm_510DA84D7642.md)
- 2017-09-30 to 2017-12-31 | money | total_assets | 21,485,000,000 United States dollar | superseded | [clm_7D68CEE62CF1](/claim/clm_7D68CEE62CF1.md)
- 2017-09-30 to 2017-12-31 | money | total_equity | 10,425,000,000 United States dollar | superseded | [clm_814865ADE6EB](/claim/clm_814865ADE6EB.md)
- 2017-12-31 to 2018-03-31 | money | cash_and_equivalents | 2,542,000,000 United States dollar | superseded | [clm_D3C2F4A0EC89](/claim/clm_D3C2F4A0EC89.md)
- 2017-12-31 to 2018-12-31 | money | net_income | 1,020,000,000 United States dollar | superseded | [clm_B9E4D0FB04B9](/claim/clm_B9E4D0FB04B9.md)
- 2017-12-31 to 2018-12-31 | money | operating_income | 2,290,000,000 United States dollar | superseded | [clm_973121336500](/claim/clm_973121336500.md)
- 2017-12-31 to 2018-12-31 | money | research_and_development | 787,000,000 United States dollar | superseded | [clm_7F4B9C2ED4BE](/claim/clm_7F4B9C2ED4BE.md)
- 2017-12-31 to 2018-12-31 | money | revenue | 12,444,000,000 United States dollar | superseded | [clm_9BFEAF075BD7](/claim/clm_9BFEAF075BD7.md)
- 2017-12-31 to 2018-03-31 | money | total_assets | 22,197,000,000 United States dollar | superseded | [clm_010921C47955](/claim/clm_010921C47955.md)
- 2017-12-31 to 2018-03-31 | money | total_equity | 9,966,000,000 United States dollar | superseded | [clm_6D31F2D60BFC](/claim/clm_6D31F2D60BFC.md)

## 2018

- 2018-01-31 to 2018-03-31 | money | shares_outstanding | 374,642,060 shares | superseded | [clm_BFD03FBC0513](/claim/clm_BFD03FBC0513.md)
- 2018-03-31 to 2018-06-30 | money | cash_and_equivalents | 2,179,000,000 United States dollar | superseded | [clm_C9B4B85611CE](/claim/clm_C9B4B85611CE.md)
- 2018-03-31 to 2018-06-30 | money | quarterly_net_income | 443,000,000 United States dollar | superseded | [clm_8C8DF1FE9B53](/claim/clm_8C8DF1FE9B53.md)
- 2018-03-31 to 2018-06-30 | money | quarterly_operating_income | 591,000,000 United States dollar | superseded | [clm_3AD1A4CBA10A](/claim/clm_3AD1A4CBA10A.md)
- 2018-03-31 to 2018-06-30 | money | quarterly_research_and_development | 204,000,000 United States dollar | superseded | [clm_4B212838AA2B](/claim/clm_4B212838AA2B.md)
- 2018-03-31 to 2018-06-30 | money | quarterly_revenue | 3,241,000,000 United States dollar | superseded | [clm_142C5B14FF64](/claim/clm_142C5B14FF64.md)
- 2018-03-31 to 2018-06-30 | money | shares_outstanding | 373,710,934 shares | superseded | [clm_9FF400C7E1DF](/claim/clm_9FF400C7E1DF.md)
- 2018-03-31 to 2018-06-30 | money | total_assets | 22,133,000,000 United States dollar | superseded | [clm_F23E44A49BA5](/claim/clm_F23E44A49BA5.md)
- 2018-03-31 to 2018-06-30 | money | total_equity | 9,214,000,000 United States dollar | superseded | [clm_C01BCE9D3CDA](/claim/clm_C01BCE9D3CDA.md)
- 2018-06-30 to 2018-09-30 | money | cash_and_equivalents | 1,641,000,000 United States dollar | superseded | [clm_3D8A982E7366](/claim/clm_3D8A982E7366.md)
- 2018-06-30 to 2018-09-30 | money | quarterly_net_income | 452,000,000 United States dollar | superseded | [clm_166DA739B7B2](/claim/clm_166DA739B7B2.md)
- 2018-06-30 to 2018-09-30 | money | quarterly_operating_income | 672,000,000 United States dollar | superseded | [clm_5B64A27065C5](/claim/clm_5B64A27065C5.md)
- 2018-06-30 to 2018-09-30 | money | quarterly_research_and_development | 216,000,000 United States dollar | superseded | [clm_206E9EB6274E](/claim/clm_206E9EB6274E.md)
- 2018-06-30 to 2018-09-30 | money | quarterly_revenue | 3,322,000,000 United States dollar | superseded | [clm_7A6FC6AA3A0D](/claim/clm_7A6FC6AA3A0D.md)
- 2018-06-30 to 2018-09-30 | money | shares_outstanding | 373,990,494 shares | superseded | [clm_44ED08B99453](/claim/clm_44ED08B99453.md)
- 2018-06-30 to 2018-09-30 | money | total_assets | 21,570,000,000 United States dollar | superseded | [clm_6D2B6F006ED8](/claim/clm_6D2B6F006ED8.md)
- 2018-06-30 to 2018-09-30 | money | total_equity | 9,460,000,000 United States dollar | superseded | [clm_9C75DAF3D2C6](/claim/clm_9C75DAF3D2C6.md)
- 2018-09-30 to 2018-12-31 | money | cash_and_equivalents | 1,918,000,000 United States dollar | superseded | [clm_7285977DFCF5](/claim/clm_7285977DFCF5.md)
- 2018-09-30 to 2019-03-31 | money | quarterly_net_income | 590,000,000 United States dollar | superseded | [clm_E36DC7AE334F](/claim/clm_E36DC7AE334F.md)
- 2018-09-30 to 2019-03-31 | money | quarterly_operating_income | 576,000,000 United States dollar | superseded | [clm_0E44C321583C](/claim/clm_0E44C321583C.md)
- 2018-09-30 to 2019-03-31 | money | quarterly_research_and_development | 221,000,000 United States dollar | superseded | [clm_73A846750188](/claim/clm_73A846750188.md)
- 2018-09-30 to 2019-03-31 | money | quarterly_revenue | 3,242,000,000 United States dollar | superseded | [clm_AC5A5FE8C379](/claim/clm_AC5A5FE8C379.md)
- 2018-09-30 to 2019-01-31 | money | shares_outstanding | 374,187,286 shares | superseded | [clm_915336B6D6A5](/claim/clm_915336B6D6A5.md)
- 2018-09-30 to 2018-12-31 | money | total_assets | 22,084,000,000 United States dollar | superseded | [clm_8E9B851AB69C](/claim/clm_8E9B851AB69C.md)
- 2018-09-30 to 2018-12-31 | money | total_equity | 9,860,000,000 United States dollar | superseded | [clm_566414C3D6BC](/claim/clm_566414C3D6BC.md)
- 2018-12-31 to 2019-03-31 | money | cash_and_equivalents | 3,616,000,000 United States dollar | superseded | [clm_6B2772627E1D](/claim/clm_6B2772627E1D.md)
- 2018-12-31 to 2019-12-31 | money | net_income | 3,553,000,000 United States dollar | superseded | [clm_AC674EC5E637](/claim/clm_AC674EC5E637.md)
- 2018-12-31 to 2019-12-31 | money | operating_income | 2,537,000,000 United States dollar | superseded | [clm_ECD0BBBBB93A](/claim/clm_ECD0BBBBB93A.md)
- 2018-12-31 to 2019-12-31 | money | research_and_development | 862,000,000 United States dollar | superseded | [clm_A81B190AB431](/claim/clm_A81B190AB431.md)
- 2018-12-31 to 2019-12-31 | money | revenue | 13,601,000,000 United States dollar | superseded | [clm_FEE1B8FE886A](/claim/clm_FEE1B8FE886A.md)
- 2018-12-31 to 2019-03-31 | money | total_assets | 27,229,000,000 United States dollar | superseded | [clm_6F9CD19E5F26](/claim/clm_6F9CD19E5F26.md)
- 2018-12-31 to 2019-03-31 | money | total_equity | 11,730,000,000 United States dollar | superseded | [clm_5E7F4020F1BF](/claim/clm_5E7F4020F1BF.md)

## 2019

- 2019-01-31 to 2019-03-31 | money | shares_outstanding | 372,664,636 shares | superseded | [clm_23346F5EE82C](/claim/clm_23346F5EE82C.md)
- 2019-03-31 to 2019-06-30 | money | cash_and_equivalents | 1,674,000,000 United States dollar | superseded | [clm_0EA4EE5B90FD](/claim/clm_0EA4EE5B90FD.md)
- 2019-03-31 to 2019-06-30 | money | quarterly_net_income | 412,000,000 United States dollar | superseded | [clm_384806036872](/claim/clm_384806036872.md)
- 2019-03-31 to 2019-06-30 | money | quarterly_operating_income | 528,000,000 United States dollar | superseded | [clm_29213B492FBA](/claim/clm_29213B492FBA.md)
- 2019-03-31 to 2019-06-30 | money | quarterly_research_and_development | 225,000,000 United States dollar | superseded | [clm_CF30656403F2](/claim/clm_CF30656403F2.md)
- 2019-03-31 to 2019-06-30 | money | quarterly_revenue | 3,516,000,000 United States dollar | superseded | [clm_F8CF3FE59B06](/claim/clm_F8CF3FE59B06.md)
- 2019-03-31 to 2019-06-30 | money | shares_outstanding | 373,810,085 shares | superseded | [clm_CA2DCEB73089](/claim/clm_CA2DCEB73089.md)
- 2019-03-31 to 2019-06-30 | money | total_assets | 25,937,000,000 United States dollar | superseded | [clm_2DCDB4D708B9](/claim/clm_2DCDB4D708B9.md)
- 2019-03-31 to 2019-06-30 | money | total_equity | 11,693,000,000 United States dollar | superseded | [clm_F93FF9F4D1B5](/claim/clm_F93FF9F4D1B5.md)
- 2019-06-30 to 2019-09-30 | money | cash_and_equivalents | 1,754,000,000 United States dollar | superseded | [clm_9A74657D6E43](/claim/clm_9A74657D6E43.md)
- 2019-06-30 to 2019-09-30 | money | quarterly_net_income | 480,000,000 United States dollar | superseded | [clm_B24CA9162373](/claim/clm_B24CA9162373.md)
- 2019-06-30 to 2019-09-30 | money | quarterly_operating_income | 613,000,000 United States dollar | superseded | [clm_B09C4F8856EC](/claim/clm_B09C4F8856EC.md)
- 2019-06-30 to 2019-09-30 | money | quarterly_research_and_development | 246,000,000 United States dollar | superseded | [clm_239E1A748D21](/claim/clm_239E1A748D21.md)
- 2019-06-30 to 2019-09-30 | money | quarterly_revenue | 3,650,000,000 United States dollar | superseded | [clm_3BA2EF6C85D5](/claim/clm_3BA2EF6C85D5.md)
- 2019-06-30 to 2019-09-30 | money | shares_outstanding | 374,103,607 shares | superseded | [clm_07C3C1DAD9A7](/claim/clm_07C3C1DAD9A7.md)
- 2019-06-30 to 2019-09-30 | money | total_assets | 26,354,000,000 United States dollar | superseded | [clm_6B113DE4A2AF](/claim/clm_6B113DE4A2AF.md)
- 2019-06-30 to 2019-09-30 | money | total_equity | 11,943,000,000 United States dollar | superseded | [clm_97666EB6E30A](/claim/clm_97666EB6E30A.md)
- 2019-09-30 to 2019-12-31 | money | cash_and_equivalents | 1,948,000,000 United States dollar | superseded | [clm_A12DB475C05B](/claim/clm_A12DB475C05B.md)
- 2019-09-30 to 2020-03-31 | money | quarterly_net_income | 466,000,000 United States dollar | superseded | [clm_975D0688D0C3](/claim/clm_975D0688D0C3.md)
- 2019-09-30 to 2020-03-31 | money | quarterly_operating_income | 628,000,000 United States dollar | superseded | [clm_668BD7ECC768](/claim/clm_668BD7ECC768.md)
- 2019-09-30 to 2020-03-31 | money | quarterly_research_and_development | 246,000,000 United States dollar | superseded | [clm_D28BC8D99637](/claim/clm_D28BC8D99637.md)
- 2019-09-30 to 2020-03-31 | money | quarterly_revenue | 3,587,000,000 United States dollar | superseded | [clm_FE7CC48A90F2](/claim/clm_FE7CC48A90F2.md)
- 2019-09-30 to 2020-01-31 | money | shares_outstanding | 374,366,776 shares | superseded | [clm_22D6CF4CF3C3](/claim/clm_22D6CF4CF3C3.md)
- 2019-09-30 to 2019-12-31 | money | total_assets | 26,659,000,000 United States dollar | superseded | [clm_53949DBBDCB2](/claim/clm_53949DBBDCB2.md)
- 2019-09-30 to 2019-12-31 | money | total_equity | 12,315,000,000 United States dollar | superseded | [clm_85F26113485E](/claim/clm_85F26113485E.md)
- 2019-12-31 to 2020-03-31 | money | cash_and_equivalents | 4,337,000,000 United States dollar | superseded | [clm_86730892E081](/claim/clm_86730892E081.md)
- 2019-12-31 to 2020-12-31 | money | net_income | 2,083,000,000 United States dollar | superseded | [clm_C0FD8BF73574](/claim/clm_C0FD8BF73574.md)
- 2019-12-31 to 2020-12-31 | money | operating_income | 2,713,000,000 United States dollar | superseded | [clm_39F85B65BE8F](/claim/clm_39F85B65BE8F.md)
- 2019-12-31 to 2020-12-31 | money | research_and_development | 971,000,000 United States dollar | superseded | [clm_0311707603F7](/claim/clm_0311707603F7.md)
- 2019-12-31 to 2020-12-31 | money | revenue | 14,884,000,000 United States dollar | superseded | [clm_2C46D5976B3D](/claim/clm_2C46D5976B3D.md)
- 2019-12-31 to 2020-03-31 | money | total_assets | 30,167,000,000 United States dollar | superseded | [clm_3FDCC73DC863](/claim/clm_3FDCC73DC863.md)
- 2019-12-31 to 2020-03-31 | money | total_equity | 12,807,000,000 United States dollar | superseded | [clm_9CF5786BE862](/claim/clm_9CF5786BE862.md)

## 2020

- 2020-01-31 to 2020-03-31 | money | shares_outstanding | 374,575,145 shares | superseded | [clm_96965895C9BE](/claim/clm_96965895C9BE.md)
- 2020-03-31 to 2020-06-30 | money | cash_and_equivalents | 3,964,000,000 United States dollar | superseded | [clm_F3B2E129D1A4](/claim/clm_F3B2E129D1A4.md)
- 2020-03-31 to 2020-06-30 | money | quarterly_net_income | 493,000,000 United States dollar | superseded | [clm_25315F1D0718](/claim/clm_25315F1D0718.md)
- 2020-03-31 to 2020-06-30 | money | quarterly_operating_income | 635,000,000 United States dollar | superseded | [clm_F2254CE46C4C](/claim/clm_F2254CE46C4C.md)
- 2020-03-31 to 2020-06-30 | money | quarterly_research_and_development | 254,000,000 United States dollar | superseded | [clm_404F7B5A8D4B](/claim/clm_404F7B5A8D4B.md)
- 2020-03-31 to 2020-06-30 | money | quarterly_revenue | 3,588,000,000 United States dollar | superseded | [clm_D86C65F9DE3F](/claim/clm_D86C65F9DE3F.md)
- 2020-03-31 to 2020-06-30 | money | shares_outstanding | 375,378,477 shares | superseded | [clm_10215670F765](/claim/clm_10215670F765.md)
- 2020-03-31 to 2020-06-30 | money | total_assets | 29,440,000,000 United States dollar | superseded | [clm_49C6D2132BDA](/claim/clm_49C6D2132BDA.md)
- 2020-03-31 to 2020-06-30 | money | total_equity | 13,115,000,000 United States dollar | superseded | [clm_529F6920E490](/claim/clm_529F6920E490.md)
- 2020-06-30 to 2020-09-30 | money | cash_and_equivalents | 6,539,000,000 United States dollar | superseded | [clm_632CC7E50B56](/claim/clm_632CC7E50B56.md)
- 2020-06-30 to 2020-09-30 | money | quarterly_net_income | -83,000,000 United States dollar | superseded | [clm_7ED77DE92A80](/claim/clm_7ED77DE92A80.md)
- 2020-06-30 to 2020-09-30 | money | quarterly_operating_income | -20,000,000 United States dollar | superseded | [clm_A04468B0236B](/claim/clm_A04468B0236B.md)
- 2020-06-30 to 2020-09-30 | money | quarterly_research_and_development | 233,000,000 United States dollar | superseded | [clm_36F0B3E6D922](/claim/clm_36F0B3E6D922.md)
- 2020-06-30 to 2020-09-30 | money | quarterly_revenue | 2,764,000,000 United States dollar | superseded | [clm_CA8B5A5A5010](/claim/clm_CA8B5A5A5010.md)
- 2020-06-30 to 2020-09-30 | money | shares_outstanding | 375,605,813 shares | superseded | [clm_1F201B828161](/claim/clm_1F201B828161.md)
- 2020-06-30 to 2020-09-30 | money | total_assets | 31,483,000,000 United States dollar | superseded | [clm_89CF1F66333D](/claim/clm_89CF1F66333D.md)
- 2020-06-30 to 2020-09-30 | money | total_equity | 12,754,000,000 United States dollar | superseded | [clm_37F31BBBC6FC](/claim/clm_37F31BBBC6FC.md)
- 2020-09-30 to 2020-12-31 | money | cash_and_equivalents | 7,083,000,000 United States dollar | superseded | [clm_6F14A1243C4C](/claim/clm_6F14A1243C4C.md)
- 2020-09-30 to 2021-03-31 | money | quarterly_net_income | 621,000,000 United States dollar | superseded | [clm_9AFE611D64A6](/claim/clm_9AFE611D64A6.md)
- 2020-09-30 to 2021-03-31 | money | quarterly_operating_income | 859,000,000 United States dollar | superseded | [clm_E3DDCD2831F6](/claim/clm_E3DDCD2831F6.md)
- 2020-09-30 to 2021-03-31 | money | quarterly_research_and_development | 242,000,000 United States dollar | superseded | [clm_3F1F450944DD](/claim/clm_3F1F450944DD.md)
- 2020-09-30 to 2021-03-31 | money | quarterly_revenue | 3,737,000,000 United States dollar | superseded | [clm_3A0C30A3001E](/claim/clm_3A0C30A3001E.md)
- 2020-09-30 to 2021-01-31 | money | shares_outstanding | 375,790,657 shares | superseded | [clm_4898674A017B](/claim/clm_4898674A017B.md)
- 2020-09-30 to 2020-12-31 | money | total_assets | 32,286,000,000 United States dollar | superseded | [clm_6E1329A8D1B7](/claim/clm_6E1329A8D1B7.md)
- 2020-09-30 to 2020-12-31 | money | total_equity | 12,986,000,000 United States dollar | superseded | [clm_FC13CCA118A9](/claim/clm_FC13CCA118A9.md)
- 2020-12-31 to 2021-03-31 | money | cash_and_equivalents | 2,943,000,000 United States dollar | superseded | [clm_E5289BAF04DB](/claim/clm_E5289BAF04DB.md)
- 2020-12-31 to 2021-12-31 | money | net_income | 1,599,000,000 United States dollar | superseded | [clm_7F3529364AEA](/claim/clm_7F3529364AEA.md)
- 2020-12-31 to 2021-12-31 | money | operating_income | 2,223,000,000 United States dollar | superseded | [clm_B7F73D9673AD](/claim/clm_B7F73D9673AD.md)
- 2020-12-31 to 2021-12-31 | money | research_and_development | 984,000,000 United States dollar | superseded | [clm_62B785D80A41](/claim/clm_62B785D80A41.md)
- 2020-12-31 to 2021-12-31 | money | revenue | 14,351,000,000 United States dollar | superseded | [clm_3FBD1E0D15C7](/claim/clm_3FBD1E0D15C7.md)
- 2020-12-31 to 2021-03-31 | money | total_assets | 34,330,000,000 United States dollar | superseded | [clm_1B7B53B5A4EF](/claim/clm_1B7B53B5A4EF.md)
- 2020-12-31 to 2021-03-31 | money | total_equity | 13,084,000,000 United States dollar | superseded | [clm_33212DF52AA6](/claim/clm_33212DF52AA6.md)

## 2021

- 2021-01-31 to 2021-03-31 | money | shares_outstanding | 376,200,942 shares | superseded | [clm_41C99FB94D2C](/claim/clm_41C99FB94D2C.md)
- 2021-03-31 to 2021-06-30 | money | cash_and_equivalents | 2,238,000,000 United States dollar | superseded | [clm_94B8F8D0E908](/claim/clm_94B8F8D0E908.md)
- 2021-03-31 to 2021-06-30 | money | quarterly_net_income | 302,000,000 United States dollar | superseded | [clm_DCEFD9F77D85](/claim/clm_DCEFD9F77D85.md)
- 2021-03-31 to 2021-06-30 | money | quarterly_operating_income | 459,000,000 United States dollar | superseded | [clm_C41FDE9399C1](/claim/clm_C41FDE9399C1.md)
- 2021-03-31 to 2021-06-30 | money | quarterly_research_and_development | 288,000,000 United States dollar | superseded | [clm_BB226C7203CD](/claim/clm_BB226C7203CD.md)
- 2021-03-31 to 2021-06-30 | money | quarterly_revenue | 3,953,000,000 United States dollar | superseded | [clm_0D4F61BB8188](/claim/clm_0D4F61BB8188.md)
- 2021-03-31 to 2021-06-30 | money | shares_outstanding | 376,747,866 shares | superseded | [clm_665DE2E83266](/claim/clm_665DE2E83266.md)
- 2021-03-31 to 2021-06-30 | money | total_assets | 33,455,000,000 United States dollar | superseded | [clm_54E13C0A5E37](/claim/clm_54E13C0A5E37.md)
- 2021-03-31 to 2021-06-30 | money | total_equity | 13,502,000,000 United States dollar | superseded | [clm_0BCBBE47AAA3](/claim/clm_0BCBBE47AAA3.md)
- 2021-06-30 to 2021-09-30 | money | cash_and_equivalents | 2,241,000,000 United States dollar | superseded | [clm_CA6DF06F86A9](/claim/clm_CA6DF06F86A9.md)
- 2021-06-30 to 2021-09-30 | money | quarterly_net_income | 592,000,000 United States dollar | superseded | [clm_DF3088439F25](/claim/clm_DF3088439F25.md)
- 2021-06-30 to 2021-09-30 | money | quarterly_operating_income | 732,000,000 United States dollar | superseded | [clm_997A8AB06997](/claim/clm_997A8AB06997.md)
- 2021-06-30 to 2021-09-30 | money | quarterly_research_and_development | 310,000,000 United States dollar | superseded | [clm_1B41C91D3765](/claim/clm_1B41C91D3765.md)
- 2021-06-30 to 2021-09-30 | money | quarterly_revenue | 4,294,000,000 United States dollar | superseded | [clm_49E3FDD42A5B](/claim/clm_49E3FDD42A5B.md)
- 2021-06-30 to 2021-09-30 | money | shares_outstanding | 377,096,272 shares | superseded | [clm_BB56BD93A9BF](/claim/clm_BB56BD93A9BF.md)
- 2021-06-30 to 2021-09-30 | money | total_assets | 33,698,000,000 United States dollar | superseded | [clm_8DE00F299F31](/claim/clm_8DE00F299F31.md)
- 2021-06-30 to 2021-09-30 | money | total_equity | 13,820,000,000 United States dollar | superseded | [clm_E294323D5A4D](/claim/clm_E294323D5A4D.md)
- 2021-09-30 to 2021-12-31 | money | cash_and_equivalents | 2,563,000,000 United States dollar | superseded | [clm_3120463C0611](/claim/clm_3120463C0611.md)
- 2021-09-30 to 2022-03-31 | money | quarterly_net_income | 438,000,000 United States dollar | superseded | [clm_932E44B2A6E6](/claim/clm_932E44B2A6E6.md)
- 2021-09-30 to 2022-03-31 | money | quarterly_operating_income | 574,000,000 United States dollar | superseded | [clm_0FF8BA480AAF](/claim/clm_0FF8BA480AAF.md)
- 2021-09-30 to 2022-03-31 | money | quarterly_research_and_development | 306,000,000 United States dollar | superseded | [clm_AE6D661B89B8](/claim/clm_AE6D661B89B8.md)
- 2021-09-30 to 2022-03-31 | money | quarterly_revenue | 4,160,000,000 United States dollar | superseded | [clm_7B7FFAF7AEFF](/claim/clm_7B7FFAF7AEFF.md)
- 2021-09-30 to 2022-01-31 | money | shares_outstanding | 377,239,958 shares | superseded | [clm_C42B98F1D35F](/claim/clm_C42B98F1D35F.md)
- 2021-09-30 to 2021-12-31 | money | total_assets | 34,145,000,000 United States dollar | superseded | [clm_B4C1D863B831](/claim/clm_B4C1D863B831.md)
- 2021-09-30 to 2021-12-31 | money | total_equity | 14,178,000,000 United States dollar | superseded | [clm_E19DAF1D43D2](/claim/clm_E19DAF1D43D2.md)
- 2021-12-31 to 2022-03-31 | money | cash_and_equivalents | 2,944,000,000 United States dollar | superseded | [clm_80AF6CA9F612](/claim/clm_80AF6CA9F612.md)
- 2021-12-31 to 2022-12-31 | money | net_income | 1,994,000,000 United States dollar | superseded | [clm_432A4C4891BE](/claim/clm_432A4C4891BE.md)
- 2021-12-31 to 2022-12-31 | money | operating_income | 2,584,000,000 United States dollar | superseded | [clm_EA33BECE4B58](/claim/clm_EA33BECE4B58.md)
- 2021-12-31 to 2022-12-31 | money | research_and_development | 1,235,000,000 United States dollar | superseded | [clm_6DB75DA59E6C](/claim/clm_6DB75DA59E6C.md)
- 2021-12-31 to 2022-12-31 | money | revenue | 17,108,000,000 United States dollar | superseded | [clm_36118C63A661](/claim/clm_36118C63A661.md)
- 2021-12-31 to 2022-03-31 | money | total_assets | 34,631,000,000 United States dollar | superseded | [clm_72263288A791](/claim/clm_72263288A791.md)
- 2021-12-31 to 2022-03-31 | money | total_equity | 14,877,000,000 United States dollar | superseded | [clm_FC92F42FF040](/claim/clm_FC92F42FF040.md)

## 2022

- 2022-01-31 to 2022-03-31 | money | shares_outstanding | 377,544,686 shares | superseded | [clm_5569A0CF037F](/claim/clm_5569A0CF037F.md)
- 2022-03-31 to 2022-06-30 | money | cash_and_equivalents | 1,458,000,000 United States dollar | superseded | [clm_BC98327D4371](/claim/clm_BC98327D4371.md)
- 2022-03-31 to 2022-06-30 | money | quarterly_net_income | 323,000,000 United States dollar | superseded | [clm_F3ABD9558B53](/claim/clm_F3ABD9558B53.md)
- 2022-03-31 to 2022-06-30 | money | quarterly_operating_income | 447,000,000 United States dollar | superseded | [clm_DEA1587275C0](/claim/clm_DEA1587275C0.md)
- 2022-03-31 to 2022-06-30 | money | quarterly_research_and_development | 413,000,000 United States dollar | superseded | [clm_A39BDA39B027](/claim/clm_A39BDA39B027.md)
- 2022-03-31 to 2022-06-30 | money | quarterly_revenue | 4,275,000,000 United States dollar | superseded | [clm_5507D61C4249](/claim/clm_5507D61C4249.md)
- 2022-03-31 to 2022-06-30 | money | shares_outstanding | 378,154,080 shares | superseded | [clm_84C323772D25](/claim/clm_84C323772D25.md)
- 2022-03-31 to 2022-06-30 | money | total_assets | 36,137,000,000 United States dollar | superseded | [clm_68834141F7C1](/claim/clm_68834141F7C1.md)
- 2022-03-31 to 2022-06-30 | money | total_equity | 15,046,000,000 United States dollar | superseded | [clm_107B0DBB9181](/claim/clm_107B0DBB9181.md)
- 2022-06-30 to 2022-09-30 | money | cash_and_equivalents | 1,044,000,000 United States dollar | superseded | [clm_9935D2C8AC64](/claim/clm_9935D2C8AC64.md)
- 2022-06-30 to 2022-09-30 | money | quarterly_net_income | 656,000,000 United States dollar | superseded | [clm_80A3EFBCBAD6](/claim/clm_80A3EFBCBAD6.md)
- 2022-06-30 to 2022-09-30 | money | quarterly_operating_income | 772,000,000 United States dollar | superseded | [clm_A7CDBD879370](/claim/clm_A7CDBD879370.md)
- 2022-06-30 to 2022-09-30 | money | quarterly_research_and_development | 351,000,000 United States dollar | superseded | [clm_3F8F3E57B28D](/claim/clm_3F8F3E57B28D.md)
- 2022-06-30 to 2022-09-30 | money | quarterly_revenue | 4,493,000,000 United States dollar | superseded | [clm_8ADB9C2732AE](/claim/clm_8ADB9C2732AE.md)
- 2022-06-30 to 2022-09-30 | money | shares_outstanding | 378,320,706 shares | superseded | [clm_8F5C73E32769](/claim/clm_8F5C73E32769.md)
- 2022-06-30 to 2022-09-30 | money | total_assets | 36,032,000,000 United States dollar | superseded | [clm_D70A27F0E17F](/claim/clm_D70A27F0E17F.md)
- 2022-06-30 to 2022-09-30 | money | total_equity | 15,674,000,000 United States dollar | superseded | [clm_E30BE138D15F](/claim/clm_E30BE138D15F.md)
- 2022-09-30 to 2022-12-31 | money | cash_and_equivalents | 1,420,000,000 United States dollar | superseded | [clm_BDEBBBB013B2](/claim/clm_BDEBBBB013B2.md)
- 2022-09-30 to 2023-03-31 | money | quarterly_net_income | 816,000,000 United States dollar | superseded | [clm_73030729A6FA](/claim/clm_73030729A6FA.md)
- 2022-09-30 to 2023-03-31 | money | quarterly_operating_income | 808,000,000 United States dollar | superseded | [clm_0F8973CB7A89](/claim/clm_0F8973CB7A89.md)
- 2022-09-30 to 2023-03-31 | money | quarterly_research_and_development | 364,000,000 United States dollar | superseded | [clm_48C1FB0058DE](/claim/clm_48C1FB0058DE.md)
- 2022-09-30 to 2023-03-31 | money | quarterly_revenue | 4,479,000,000 United States dollar | superseded | [clm_0CC54F791D54](/claim/clm_0CC54F791D54.md)
- 2022-09-30 to 2023-01-31 | money | shares_outstanding | 378,429,929 shares | superseded | [clm_6291C6304B5B](/claim/clm_6291C6304B5B.md)
- 2022-09-30 to 2022-12-31 | money | total_assets | 35,983,000,000 United States dollar | superseded | [clm_5313C6A9989F](/claim/clm_5313C6A9989F.md)
- 2022-09-30 to 2022-12-31 | money | total_equity | 16,463,000,000 United States dollar | superseded | [clm_65F9A96B83C9](/claim/clm_65F9A96B83C9.md)
- 2022-12-31 to 2023-03-31 | money | cash_and_equivalents | 1,844,000,000 United States dollar | superseded | [clm_5E3498F188C1](/claim/clm_5E3498F188C1.md)
- 2022-12-31 to 2023-12-31 | money | net_income | 2,358,000,000 United States dollar | superseded | [clm_4EEAAAAA1630](/claim/clm_4EEAAAAA1630.md)
- 2022-12-31 to 2023-12-31 | money | operating_income | 2,841,000,000 United States dollar | superseded | [clm_4EE3A3B66706](/claim/clm_4EE3A3B66706.md)
- 2022-12-31 to 2023-12-31 | money | research_and_development | 1,454,000,000 United States dollar | superseded | [clm_BD2BED34F69F](/claim/clm_BD2BED34F69F.md)
- 2022-12-31 to 2023-12-31 | money | revenue | 18,449,000,000 United States dollar | superseded | [clm_40407F60BA3F](/claim/clm_40407F60BA3F.md)
- 2022-12-31 to 2023-03-31 | money | total_assets | 36,884,000,000 United States dollar | superseded | [clm_FF47E396CE9D](/claim/clm_FF47E396CE9D.md)
- 2022-12-31 to 2023-03-31 | money | total_equity | 16,616,000,000 United States dollar | superseded | [clm_EADAEE8199F9](/claim/clm_EADAEE8199F9.md)

## 2023

- 2023-01-31 to 2023-03-31 | money | shares_outstanding | 378,831,249 shares | superseded | [clm_2FEC5DEE424B](/claim/clm_2FEC5DEE424B.md)
- 2023-03-31 to 2023-06-30 | money | cash_and_equivalents | 1,671,000,000 United States dollar | superseded | [clm_50097DFC71B2](/claim/clm_50097DFC71B2.md)
- 2023-03-31 to 2023-06-30 | money | quarterly_net_income | 592,000,000 United States dollar | superseded | [clm_2ABE3E89FE3C](/claim/clm_2ABE3E89FE3C.md)
- 2023-03-31 to 2023-06-30 | money | quarterly_operating_income | 735,000,000 United States dollar | superseded | [clm_83888291EC11](/claim/clm_83888291EC11.md)
- 2023-03-31 to 2023-06-30 | money | quarterly_research_and_development | 339,000,000 United States dollar | superseded | [clm_E44F94D81C65](/claim/clm_E44F94D81C65.md)
- 2023-03-31 to 2023-06-30 | money | quarterly_revenue | 4,778,000,000 United States dollar | superseded | [clm_620DA81F4D50](/claim/clm_620DA81F4D50.md)
- 2023-03-31 to 2023-06-30 | money | shares_outstanding | 379,608,166 shares | superseded | [clm_7F25DAFD7603](/claim/clm_7F25DAFD7603.md)
- 2023-03-31 to 2023-06-30 | money | total_assets | 36,830,000,000 United States dollar | superseded | [clm_A6EF509A5FCA](/claim/clm_A6EF509A5FCA.md)
- 2023-03-31 to 2023-06-30 | money | total_equity | 16,895,000,000 United States dollar | superseded | [clm_458E880D987A](/claim/clm_458E880D987A.md)
- 2023-06-30 to 2023-09-30 | money | cash_and_equivalents | 1,401,000,000 United States dollar | superseded | [clm_E2474AE85325](/claim/clm_E2474AE85325.md)
- 2023-06-30 to 2023-09-30 | money | quarterly_net_income | 738,000,000 United States dollar | superseded | [clm_4B846588B3B6](/claim/clm_4B846588B3B6.md)
- 2023-06-30 to 2023-09-30 | money | quarterly_operating_income | 965,000,000 United States dollar | superseded | [clm_6752357B61EC](/claim/clm_6752357B61EC.md)
- 2023-06-30 to 2023-09-30 | money | quarterly_research_and_development | 346,000,000 United States dollar | superseded | [clm_BE103908FA5C](/claim/clm_BE103908FA5C.md)
- 2023-06-30 to 2023-09-30 | money | quarterly_revenue | 4,996,000,000 United States dollar | superseded | [clm_E90C0FCB11CB](/claim/clm_E90C0FCB11CB.md)
- 2023-06-30 to 2023-09-30 | money | shares_outstanding | 379,778,279 shares | superseded | [clm_7347E897CAA6](/claim/clm_7347E897CAA6.md)
- 2023-06-30 to 2023-09-30 | money | total_assets | 37,409,000,000 United States dollar | superseded | [clm_B2C741C020E2](/claim/clm_B2C741C020E2.md)
- 2023-06-30 to 2023-09-30 | money | total_equity | 17,361,000,000 United States dollar | superseded | [clm_FB32E898682F](/claim/clm_FB32E898682F.md)
- 2023-09-30 to 2023-12-31 | money | cash_and_equivalents | 1,860,000,000 United States dollar | superseded | [clm_759592C24E7E](/claim/clm_759592C24E7E.md)
- 2023-09-30 to 2024-03-31 | money | quarterly_net_income | 692,000,000 United States dollar | superseded | [clm_134D44728A08](/claim/clm_134D44728A08.md)
- 2023-09-30 to 2024-03-31 | money | quarterly_operating_income | 931,000,000 United States dollar | superseded | [clm_73911C54E4C5](/claim/clm_73911C54E4C5.md)
- 2023-09-30 to 2024-03-31 | money | quarterly_research_and_development | 353,000,000 United States dollar | superseded | [clm_16FF9A9D41FF](/claim/clm_16FF9A9D41FF.md)
- 2023-09-30 to 2024-03-31 | money | quarterly_revenue | 4,909,000,000 United States dollar | superseded | [clm_6BB4A13B7973](/claim/clm_6BB4A13B7973.md)
- 2023-09-30 to 2024-01-31 | money | shares_outstanding | 379,894,650 shares | superseded | [clm_FF73E3451A99](/claim/clm_FF73E3451A99.md)
- 2023-09-30 to 2023-12-31 | money | total_assets | 38,042,000,000 United States dollar | superseded | [clm_63C0089299CE](/claim/clm_63C0089299CE.md)
- 2023-09-30 to 2023-12-31 | money | total_equity | 17,905,000,000 United States dollar | superseded | [clm_FB65BB756D49](/claim/clm_FB65BB756D49.md)
- 2023-12-31 to 2024-03-31 | money | cash_and_equivalents | 2,971,000,000 United States dollar | superseded | [clm_56B8F46418B7](/claim/clm_56B8F46418B7.md)
- 2023-12-31 to 2024-12-31 | money | net_income | 3,165,000,000 United States dollar | superseded | [clm_A4432174E550](/claim/clm_A4432174E550.md)
- 2023-12-31 to 2024-12-31 | money | operating_income | 3,888,000,000 United States dollar | superseded | [clm_BAFC137FE99D](/claim/clm_BAFC137FE99D.md)
- 2023-12-31 to 2024-12-31 | money | research_and_development | 1,388,000,000 United States dollar | superseded | [clm_356C61D74C38](/claim/clm_356C61D74C38.md)
- 2023-12-31 to 2024-12-31 | money | revenue | 20,498,000,000 United States dollar | superseded | [clm_C62E4500ABDC](/claim/clm_C62E4500ABDC.md)
- 2023-12-31 to 2024-03-31 | money | total_assets | 39,912,000,000 United States dollar | superseded | [clm_BD268F9A723D](/claim/clm_BD268F9A723D.md)
- 2023-12-31 to 2024-03-31 | money | total_equity | 18,593,000,000 United States dollar | superseded | [clm_B0598FAB3B66](/claim/clm_B0598FAB3B66.md)

## 2024

- 2024-01-31 to 2024-03-31 | money | shares_outstanding | 380,264,036 shares | superseded | [clm_7E342FF09D5C](/claim/clm_7E342FF09D5C.md)
- 2024-03-31 to 2024-06-30 | money | cash_and_equivalents | 2,330,000,000 United States dollar | superseded | [clm_C882425727AE](/claim/clm_C882425727AE.md)
- 2024-03-31 to 2024-06-30 | money | quarterly_net_income | 788,000,000 United States dollar | superseded | [clm_DE9BF490C57B](/claim/clm_DE9BF490C57B.md)
- 2024-03-31 to 2024-06-30 | money | quarterly_operating_income | 972,000,000 United States dollar | superseded | [clm_0EC5837F2932](/claim/clm_0EC5837F2932.md)
- 2024-03-31 to 2024-06-30 | money | quarterly_research_and_development | 368,000,000 United States dollar | superseded | [clm_7C8827883B7B](/claim/clm_7C8827883B7B.md)
- 2024-03-31 to 2024-06-30 | money | quarterly_revenue | 5,243,000,000 United States dollar | superseded | [clm_4FCA84C9527C](/claim/clm_4FCA84C9527C.md)
- 2024-03-31 to 2024-06-30 | money | shares_outstanding | 380,949,778 shares | superseded | [clm_AEBBBE0C8CC6](/claim/clm_AEBBBE0C8CC6.md)
- 2024-03-31 to 2024-06-30 | money | total_assets | 39,402,000,000 United States dollar | superseded | [clm_F25E74CC35B7](/claim/clm_F25E74CC35B7.md)
- 2024-03-31 to 2024-06-30 | money | total_equity | 19,172,000,000 United States dollar | superseded | [clm_E780EF28D3DE](/claim/clm_E780EF28D3DE.md)
- 2024-06-30 to 2024-09-30 | money | cash_and_equivalents | 1,874,000,000 United States dollar | superseded | [clm_3279E14170A7](/claim/clm_3279E14170A7.md)
- 2024-06-30 to 2024-09-30 | money | quarterly_net_income | 825,000,000 United States dollar | superseded | [clm_160857527ECA](/claim/clm_160857527ECA.md)
- 2024-06-30 to 2024-09-30 | money | quarterly_operating_income | 1,051,000,000 United States dollar | superseded | [clm_66DD8507F180](/claim/clm_66DD8507F180.md)
- 2024-06-30 to 2024-09-30 | money | quarterly_research_and_development | 363,000,000 United States dollar | superseded | [clm_C535C15C7FA3](/claim/clm_C535C15C7FA3.md)
- 2024-06-30 to 2024-09-30 | money | quarterly_revenue | 5,422,000,000 United States dollar | superseded | [clm_92DA0A2215E9](/claim/clm_92DA0A2215E9.md)
- 2024-06-30 to 2024-09-30 | money | shares_outstanding | 381,075,364 shares | superseded | [clm_2C64CA1A6809](/claim/clm_2C64CA1A6809.md)
- 2024-06-30 to 2024-09-30 | money | total_assets | 39,130,000,000 United States dollar | superseded | [clm_30E8817B9D65](/claim/clm_30E8817B9D65.md)
- 2024-06-30 to 2024-09-30 | money | total_equity | 19,762,000,000 United States dollar | superseded | [clm_7F8FFC97DB5D](/claim/clm_7F8FFC97DB5D.md)
- 2024-09-30 to 2024-12-31 | money | cash_and_equivalents | 3,850,000,000 United States dollar | superseded | [clm_9E7D2C63C45D](/claim/clm_9E7D2C63C45D.md)
- 2024-09-30 to 2025-03-31 | money | quarterly_net_income | 834,000,000 United States dollar | superseded | [clm_1F37CA2E62A9](/claim/clm_1F37CA2E62A9.md)
- 2024-09-30 to 2025-03-31 | money | quarterly_operating_income | 1,085,000,000 United States dollar | superseded | [clm_7E2205B81DC8](/claim/clm_7E2205B81DC8.md)
- 2024-09-30 to 2025-03-31 | money | quarterly_research_and_development | 377,000,000 United States dollar | superseded | [clm_9E4B395BF18B](/claim/clm_9E4B395BF18B.md)
- 2024-09-30 to 2025-03-31 | money | quarterly_revenue | 5,494,000,000 United States dollar | superseded | [clm_B16FF22B9E44](/claim/clm_B16FF22B9E44.md)
- 2024-09-30 to 2025-01-31 | money | shares_outstanding | 381,215,773 shares | superseded | [clm_B5A964A41635](/claim/clm_B5A964A41635.md)
- 2024-09-30 to 2024-12-31 | money | total_assets | 43,833,000,000 United States dollar | superseded | [clm_330E86BCCC8E](/claim/clm_330E86BCCC8E.md)
- 2024-09-30 to 2024-12-31 | money | total_equity | 20,149,000,000 United States dollar | superseded | [clm_63BF10208C6C](/claim/clm_63BF10208C6C.md)
- 2024-12-31 to 2025-03-31 | money | cash_and_equivalents | 3,652,000,000 United States dollar | superseded | [clm_F02E8B934587](/claim/clm_F02E8B934587.md)
- 2024-12-31 to 2025-12-31 | money | net_income | 2,993,000,000 United States dollar | superseded | [clm_8D6AA07518A6](/claim/clm_8D6AA07518A6.md)
- 2024-12-31 to 2025-12-31 | money | operating_income | 3,689,000,000 United States dollar | superseded | [clm_5442DF8B2745](/claim/clm_5442DF8B2745.md)
- 2024-12-31 to 2025-12-31 | money | research_and_development | 1,466,000,000 United States dollar | superseded | [clm_EC0F2D5205F4](/claim/clm_EC0F2D5205F4.md)
- 2024-12-31 to 2025-12-31 | money | revenue | 22,595,000,000 United States dollar | superseded | [clm_D8DB92A640FC](/claim/clm_D8DB92A640FC.md)
- 2024-12-31 to 2025-03-31 | money | total_assets | 42,971,000,000 United States dollar | superseded | [clm_A908191DE631](/claim/clm_A908191DE631.md)
- 2024-12-31 to 2025-03-31 | money | total_equity | 20,634,000,000 United States dollar | superseded | [clm_12BE51995F1A](/claim/clm_12BE51995F1A.md)

## 2025

- 2025-01-06 | money | agreement | Inari Medical, Inc. | valid | [clm_94085C3804FF](/claim/clm_94085C3804FF.md)
- 2025-01-31 to 2025-03-31 | money | shares_outstanding | 381,579,123 shares | superseded | [clm_70BB8F19F91A](/claim/clm_70BB8F19F91A.md)
- 2025-02-19 | money | acquired | Inari Medical, Inc. | valid | [clm_DAABC8F362A5](/claim/clm_DAABC8F362A5.md)
- 2025-03-31 to 2025-06-30 | money | cash_and_equivalents | 2,320,000,000 United States dollar | superseded | [clm_FAEBBC1425D0](/claim/clm_FAEBBC1425D0.md)
- 2025-03-31 to 2025-06-30 | money | quarterly_net_income | 654,000,000 United States dollar | superseded | [clm_F4336F214A29](/claim/clm_F4336F214A29.md)
- 2025-03-31 to 2025-06-30 | money | quarterly_operating_income | 837,000,000 United States dollar | superseded | [clm_0644B8D40D3E](/claim/clm_0644B8D40D3E.md)
- 2025-03-31 to 2025-06-30 | money | quarterly_research_and_development | 405,000,000 United States dollar | superseded | [clm_7C5C7D59116D](/claim/clm_7C5C7D59116D.md)
- 2025-03-31 to 2025-06-30 | money | quarterly_revenue | 5,866,000,000 United States dollar | superseded | [clm_7E50B7B71F73](/claim/clm_7E50B7B71F73.md)
- 2025-03-31 to 2025-06-30 | money | shares_outstanding | 382,164,865 shares | superseded | [clm_09A7CDC507FF](/claim/clm_09A7CDC507FF.md)
- 2025-03-31 to 2025-06-30 | money | total_assets | 46,006,000,000 United States dollar | superseded | [clm_D3862E470779](/claim/clm_D3862E470779.md)
- 2025-03-31 to 2025-06-30 | money | total_equity | 20,930,000,000 United States dollar | superseded | [clm_D106767DC80D](/claim/clm_D106767DC80D.md)
- 2025-06-30 to 2025-09-30 | money | cash_and_equivalents | 2,375,000,000 United States dollar | superseded | [clm_A6E16A5A3D39](/claim/clm_A6E16A5A3D39.md)
- 2025-06-30 to 2025-09-30 | money | quarterly_net_income | 884,000,000 United States dollar | superseded | [clm_219472BC9759](/claim/clm_219472BC9759.md)
- 2025-06-30 to 2025-09-30 | money | quarterly_operating_income | 1,113,000,000 United States dollar | superseded | [clm_5F5ED68B0ECB](/claim/clm_5F5ED68B0ECB.md)
- 2025-06-30 to 2025-09-30 | money | quarterly_research_and_development | 407,000,000 United States dollar | superseded | [clm_B39091391EB0](/claim/clm_B39091391EB0.md)
- 2025-06-30 to 2025-09-30 | money | quarterly_revenue | 6,022,000,000 United States dollar | superseded | [clm_BA97FB0A4275](/claim/clm_BA97FB0A4275.md)
- 2025-06-30 to 2025-09-30 | money | shares_outstanding | 382,307,298 shares | superseded | [clm_EDD77685BC04](/claim/clm_EDD77685BC04.md)
- 2025-06-30 to 2025-09-30 | money | total_assets | 46,331,000,000 United States dollar | superseded | [clm_1870F1D404F5](/claim/clm_1870F1D404F5.md)
- 2025-06-30 to 2025-09-30 | money | total_equity | 21,191,000,000 United States dollar | superseded | [clm_EE223BA502CD](/claim/clm_EE223BA502CD.md)
- 2025-09-30 to 2025-12-31 | money | cash_and_equivalents | 3,256,000,000 United States dollar | superseded | [clm_3DD0AACD5492](/claim/clm_3DD0AACD5492.md)
- 2025-09-30 to 2026-03-31 | money | quarterly_net_income | 859,000,000 United States dollar | superseded | [clm_D8A0D107B7F6](/claim/clm_D8A0D107B7F6.md)
- 2025-09-30 to 2026-03-31 | money | quarterly_operating_income | 1,135,000,000 United States dollar | superseded | [clm_B72036341823](/claim/clm_B72036341823.md)
- 2025-09-30 to 2026-03-31 | money | quarterly_research_and_development | 410,000,000 United States dollar | superseded | [clm_840CBFF64E83](/claim/clm_840CBFF64E83.md)
- 2025-09-30 to 2026-03-31 | money | quarterly_revenue | 6,057,000,000 United States dollar | superseded | [clm_8E877412AAEE](/claim/clm_8E877412AAEE.md)
- 2025-09-30 to 2026-01-31 | money | shares_outstanding | 382,423,648 shares | superseded | [clm_53217597F2B0](/claim/clm_53217597F2B0.md)
- 2025-09-30 to 2025-12-31 | money | total_assets | 47,057,000,000 United States dollar | superseded | [clm_1B2097560390](/claim/clm_1B2097560390.md)
- 2025-09-30 to 2025-12-31 | money | total_equity | 21,785,000,000 United States dollar | superseded | [clm_5C2DB82E169E](/claim/clm_5C2DB82E169E.md)
- 2025-12-31 to 2026-03-31 | money | cash_and_equivalents | 4,011,000,000 United States dollar | superseded | [clm_01F1E3D2AFA5](/claim/clm_01F1E3D2AFA5.md)
- 2025-12-31 | money | net_income | 3,246,000,000 United States dollar | valid | [clm_67A3BD4DA5CA](/claim/clm_67A3BD4DA5CA.md)
- 2025-12-31 | money | operating_income | 4,889,000,000 United States dollar | valid | [clm_57564F6F4242](/claim/clm_57564F6F4242.md)
- 2025-12-31 | money | research_and_development | 1,623,000,000 United States dollar | valid | [clm_DAC9135A26A9](/claim/clm_DAC9135A26A9.md)
- 2025-12-31 | money | revenue | 25,116,000,000 United States dollar | valid | [clm_2711436885CB](/claim/clm_2711436885CB.md)
- 2025-12-31 to 2026-03-31 | money | total_assets | 47,844,000,000 United States dollar | superseded | [clm_1C3EDF939FE8](/claim/clm_1C3EDF939FE8.md)
- 2025-12-31 to 2026-03-31 | money | total_equity | 22,420,000,000 United States dollar | superseded | [clm_6E60905B1047](/claim/clm_6E60905B1047.md)

## 2026

- 2026-01-31 to 2026-03-31 | money | shares_outstanding | 382,688,675 shares | superseded | [clm_E8EFDF649C1E](/claim/clm_E8EFDF649C1E.md)
- 2026-03-31 to 2026-06-30 | money | cash_and_equivalents | 2,878,000,000 United States dollar | superseded | [clm_985B3538CAF1](/claim/clm_985B3538CAF1.md)
- 2026-03-31 to 2026-06-30 | money | quarterly_net_income | 745,000,000 United States dollar | superseded | [clm_E3E05BB77AD2](/claim/clm_E3E05BB77AD2.md)
- 2026-03-31 to 2026-06-30 | money | quarterly_operating_income | 936,000,000 United States dollar | superseded | [clm_F2E70133269B](/claim/clm_F2E70133269B.md)
- 2026-03-31 to 2026-06-30 | money | quarterly_research_and_development | 413,000,000 United States dollar | superseded | [clm_0B263C3D2C56](/claim/clm_0B263C3D2C56.md)
- 2026-03-31 to 2026-06-30 | money | quarterly_revenue | 6,020,000,000 United States dollar | superseded | [clm_14534DCC89AD](/claim/clm_14534DCC89AD.md)
- 2026-03-31 to 2026-06-30 | money | shares_outstanding | 383,360,762 shares | superseded | [clm_2452BE201213](/claim/clm_2452BE201213.md)
- 2026-03-31 to 2026-06-30 | money | total_assets | 46,291,000,000 United States dollar | superseded | [clm_62C4C7E7F9B5](/claim/clm_62C4C7E7F9B5.md)
- 2026-03-31 to 2026-06-30 | money | total_equity | 22,979,000,000 United States dollar | superseded | [clm_F4FB345DC757](/claim/clm_F4FB345DC757.md)
- 2026-06-30 to 2026-09-30 | money | cash_and_equivalents | 3,391,000,000 United States dollar | superseded | [clm_7EDF7EEA8C6F](/claim/clm_7EDF7EEA8C6F.md)
- 2026-06-30 to 2026-09-30 | money | quarterly_net_income | 1,276,000,000 United States dollar | superseded | [clm_4D0E87EFBB8C](/claim/clm_4D0E87EFBB8C.md)
- 2026-06-30 to 2026-09-30 | money | quarterly_operating_income | 1,659,000,000 United States dollar | superseded | [clm_01CBABA1BBEB](/claim/clm_01CBABA1BBEB.md)
- 2026-06-30 to 2026-09-30 | money | quarterly_research_and_development | 434,000,000 United States dollar | superseded | [clm_7BA4911CD0D8](/claim/clm_7BA4911CD0D8.md)
- 2026-06-30 to 2026-09-30 | money | quarterly_revenue | 6,589,000,000 United States dollar | superseded | [clm_81C6EB299F23](/claim/clm_81C6EB299F23.md)
- 2026-06-30 to 2026-09-30 | money | shares_outstanding | 383,573,046 shares | superseded | [clm_AF7B38A6E983](/claim/clm_AF7B38A6E983.md)
- 2026-06-30 to 2026-09-30 | money | total_assets | 47,930,000,000 United States dollar | superseded | [clm_1DEE2C9335E3](/claim/clm_1DEE2C9335E3.md)
- 2026-06-30 to 2026-09-30 | money | total_equity | 23,988,000,000 United States dollar | superseded | [clm_879576B2DBD5](/claim/clm_879576B2DBD5.md)
- 2026-09-30 | money | cash_and_equivalents | 3,271,000,000 United States dollar | valid | [clm_081F1213F18C](/claim/clm_081F1213F18C.md)
- 2026-09-30 | money | quarterly_net_income | 753,000,000 United States dollar | valid | [clm_35B4FBD845E2](/claim/clm_35B4FBD845E2.md)
- 2026-09-30 | money | quarterly_operating_income | 1,034,000,000 United States dollar | valid | [clm_AE0E97F1AC79](/claim/clm_AE0E97F1AC79.md)
- 2026-09-30 | money | quarterly_research_and_development | 433,000,000 United States dollar | valid | [clm_9A4F807637F2](/claim/clm_9A4F807637F2.md)
- 2026-09-30 | money | quarterly_revenue | 6,520,000,000 United States dollar | valid | [clm_08A9619123F8](/claim/clm_08A9619123F8.md)
- 2026-09-30 | money | shares_outstanding | 380,691,004 shares | valid | [clm_2175673D8B90](/claim/clm_2175673D8B90.md)
- 2026-09-30 | money | total_assets | 47,247,000,000 United States dollar | valid | [clm_B99FA67BFA76](/claim/clm_B99FA67BFA76.md)
- 2026-09-30 | money | total_equity | 23,457,000,000 United States dollar | valid | [clm_7FA8580013B6](/claim/clm_7FA8580013B6.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.